<SEC-DOCUMENT>0001571049-16-014099.txt : 20160421
<SEC-HEADER>0001571049-16-014099.hdr.sgml : 20160421
<ACCEPTANCE-DATETIME>20160421160517
ACCESSION NUMBER:		0001571049-16-014099
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20160608
FILED AS OF DATE:		20160421
DATE AS OF CHANGE:		20160421
EFFECTIVENESS DATE:		20160421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		161584121

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>t1600224_def14a.htm
<DESCRIPTION>SCHEDULE 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549<BR>
<BR>
</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE 14A<BR>
<BR>
</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Proxy Statement Pursuant to Section
14(a) of<BR>
the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 30%; font-size: 10pt">Filed by the Registrant <font style="font-family: Wingdings">x</font></td>
    <TD STYLE="width: 70%; font-size: 10pt">Filed by a Party other than the Registrant <font style="font-family: Wingdings">&uml;</font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 97%">Preliminary Proxy Statement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 97%"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings">x</FONT></TD><TD STYLE="width: 97%">Definitive Proxy Statement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 97%">Definitive Additional Materials</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 97%">Soliciting Material Pursuant to &sect;240.14a-12</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Applied DNA Sciences, Inc.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified In Its Charter)<BR>
<BR>
</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">x</FONT> No fee
required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Fee computed
on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.15in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in">1)</TD><TD>Title of each class of securities to which transaction applies:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in">2)</TD><TD>Aggregate number of securities to which transaction applies:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in">3)</TD><TD>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was determined):</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in">4)</TD><TD>Proposed maximum aggregate value of transaction:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in">5)</TD><TD>Total fee paid:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Fee
paid previously with preliminary materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Check box
if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its
filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.15in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in">1)</TD><TD>Amount Previously Paid:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in">2)</TD><TD>Form, Schedule or Registration Statement No.:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in">3)</TD><TD>Filing Party:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.15in"></TD><TD STYLE="width: 0.15in">4)</TD><TD>Date Filed:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.15in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.15in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.15in"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><img src="logo.jpg"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES,&nbsp;INC.</B><BR>
50 HEALTH SCIENCES DRIVE<BR>
STONY BROOK, NEW YORK 11790<BR>
(631) 240-8800<BR>
<BR>
April 29, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Fellow Stockholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You are cordially invited to attend the
2016 Annual Meeting of Stockholders of Applied DNA Sciences,&nbsp;Inc. (&ldquo;<I>Applied DNA Sciences</I>,&rdquo; the &ldquo;<I>Company</I>,&rdquo;
&ldquo;<I>we</I>&rdquo; or &ldquo;<I>us</I>&rdquo;) to be held at <B>10:00&nbsp;a.m., local time</B>, on <B>Wednesday, June 8,
2016</B>, at the Center of Excellence in Wireless and Information Technology, Stony Brook, New York 11794.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At the meeting, you will be asked to elect
six directors, approve, on a non-binding, advisory basis, the compensation of the Company&rsquo;s named executive officers, and
ratify our appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending September
30, 2016.&nbsp;&nbsp;In addition, we will be pleased to report on our affairs and a discussion period will be provided for questions
and comments of general interest to stockholders. Detailed information with respect to these matters is set forth in the accompanying
Proxy Statement, which we encourage you to carefully read in its entirety.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We look forward to greeting personally those
stockholders who are able to attend the meeting in person.&nbsp;&nbsp;However, whether or not you plan to be with us at the meeting,
it is important that your shares be represented.&nbsp;&nbsp;Stockholders of record at the close of business on April 11, 2016 are
entitled to notice of and to vote at the meeting. We will be using the &ldquo;Notice and Access&rdquo; method of providing proxy
materials to you via the Internet. On or about April 29, 2016, we will mail to our stockholders a Notice of Availability of Proxy
Materials (&ldquo;<I>Notice</I>&rdquo;) containing instructions on how to access our Proxy Statement and our 2015 Annual Report
and vote electronically via the Internet. The Notice also contains instructions on how to receive a paper copy of your proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You may vote over the Internet, as well
as by telephone or, if you requested to receive printed proxy materials, you can also vote by mail&nbsp;pursuant to instructions
provided on the proxy card.&nbsp;&nbsp;Please review the instructions on each of your voting options described in the Proxy Statement,
as well as in the Notice you will receive in the mail. Please note that each stockholder who wishes to attend the Annual Meeting
will be required to present valid government-issued photo identification to be admitted to the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Thank you for your ongoing support of Applied
DNA Sciences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt times new roman; width: 100%; background-color: white">
<tr style="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</td>
    <TD STYLE="width: 30%">Very truly yours,</td>
    <TD STYLE="width: 10%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ James A. Hayward</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>James A. Hayward</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD><i>Chairman, President</i></td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD><i>and Chief Executive Officer</i></td>
    <TD>&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APPLIED DNA SCIENCES,&nbsp;INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr>
    <TD STYLE="width: 100%; border-top: Black 2px solid">&nbsp;</td></tr>
<tr>
    <td style="text-align: center"><b>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</b></td></tr>
<tr>
    <TD STYLE="border-bottom: Black 2px solid">&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notice is hereby given that the 2016 Annual
Meeting of Stockholders (the &ldquo;<I>Annual Meeting</I>&rdquo;) of Applied DNA Sciences,&nbsp;Inc. (&ldquo;<I>Applied DNA Sciences</I>&rdquo;
or the &ldquo;<I>Company</I>&rdquo;), will be held on Wednesday, June 8, 2016 at 10:00&nbsp;a.m., local time, at the Center of
Excellence in Wireless and Information Technology, Stony Brook, New York 11794 for the following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to elect six directors, constituting the entire board of directors of the Company (the &ldquo;<I>Board of Directors</I>&rdquo;
or &ldquo;<I>Board</I>&rdquo;), to serve until the Company&rsquo;s next annual meeting of stockholders or until their respective
successors are duly elected and qualified;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to approve, on a non-binding, advisory basis, the compensation of the Company&rsquo;s named executive officers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending September
30, 2016; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the
meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">These matters are more fully described in
the accompanying Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Only stockholders of record at the close
of business on April 11, 2016 are entitled to notice of and to vote at the meeting or any postponements or adjournments of the
meeting.&nbsp;&nbsp;A list of stockholders eligible to vote at the meeting will be available for inspection at the meeting and
for a period of ten days prior to the meeting during regular business hours at our corporate headquarters at Applied DNA Sciences,
50 Health Sciences Drive, Stony Brook, New York 11790. On or about April 29, 2016, the Company will mail to stockholders a Notice
of Availability of Proxy Materials containing instructions on how to access our Proxy Statement and our 2015 Annual Report and
vote electronically via the Internet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Your vote is very important.&nbsp;&nbsp;Whether
or not you plan to attend the Annual Meeting, we encourage you to read the Proxy Statement and submit your proxy or voting instructions
as soon as possible by Internet, telephone or mail.&nbsp;&nbsp;For specific instructions on how to vote your shares, please refer
to the instructions on the Notice of Internet Availability of Proxy Materials you will receive in the mail, the section entitled
&ldquo;About the Annual Meeting&rdquo; beginning on page 1 of the Proxy Statement or, if you request to receive printed proxy materials,
your enclosed proxy card. Please note that shares held beneficially in street name may be voted by you in person at the Annual
Meeting only if you obtain a legal proxy from the broker, bank, trustee, or other nominee that holds your shares giving you the
right to vote the shares.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stony Brook, New York<br>
        April 29, 2016</P></td>
    <td style="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-variant: small-caps">Dr. Ming-Hwa Benjamin
        Liang</font></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Secretary</i></P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Important Notice Regarding the Availability
of Proxy Materials<BR>
for the Annual Meeting of Stockholders<BR>
To Be Held on June 8, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Proxy Statement, along with our 2015 Annual Report, is
available free of charge at the following website: <U>www.proxyvote.com</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Table of Contents</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD STYLE="width: 90%"><A HREF="#dna_001">ABOUT THE ANNUAL MEETING</A></TD>
    <TD STYLE="width: 10%; text-align: right; vertical-align: bottom">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_002">PROPOSAL NO. 1&mdash; ELECTION OF DIRECTORS</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">6</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_003">PROPOSAL NO. 2&mdash; NON-BINDING, ADVISORY APPROVAL OF THE COMPENSATION OF THE COMPANY&rsquo;S NAMED EXECUTIVE OFFICERS</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">10</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_004">PROPOSAL NO. 3&mdash; RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">12</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_005">MANAGEMENT AND CORPORATE GOVERNANCE</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">16</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_006">EXECUTIVE COMPENSATION</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">21</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_007">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">31</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_008">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">32</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_009">HOUSEHOLDING OF PROXY MATERIALS</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">34</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_010">OTHER BUSINESS</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">34</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_011">STOCKHOLDER PROPOSALS AND NOMINATIONS</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">34</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: Azure">
    <TD><A HREF="#dna_012">ANNUAL REPORT ON FORM 10-K AND OTHER INFORMATION</A></TD>
    <TD STYLE="text-align: right; vertical-align: bottom">35</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APPLIED DNA SCIENCES,&nbsp;INC.<BR>
50 HEALTH SCIENCES DRIVE<BR>
STONY BROOK, NEW YORK 11790</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr>
    <TD STYLE="width: 100%; border-top: Black 2px solid">&nbsp;</td></tr>
<tr>
    <td style="text-align: center"><b>PROXY STATEMENT</b></td></tr>
<tr>
    <TD STYLE="border-bottom: Black 2px solid">&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board of Directors has made this Proxy
Statement and related materials available to you on the Internet, or, upon your request, has delivered printed proxy materials
to you by mail, in connection with the Board of Directors&rsquo; solicitation of proxies for use at the 2016 Annual Meeting of
Stockholders of Applied DNA Sciences to be held on June 8, 2016, beginning at 10:00&nbsp;a.m., local time, at the Center of Excellence
in Wireless and Information Technology, Stony Brook, New York 11794, and at any postponements or adjournments of the Annual Meeting.&nbsp;&nbsp;As
a stockholder, you are invited to attend the Annual Meeting and are requested to vote on the items of business described in this
Proxy Statement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_001"></A>ABOUT THE ANNUAL
MEETING</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Why did I receive a notice in the mail regarding
the Internet availability of proxy materials instead of a full set of proxy materials?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with rules adopted by the
Securities and Exchange Commission (&ldquo;<I>SEC</I>&rdquo;), we are providing access to our proxy materials over the Internet.&nbsp;&nbsp;Accordingly,
we are sending a Notice Regarding Availability of Proxy Materials (the &ldquo;<I>Notice</I>&rdquo;) to our stockholders of record
and beneficial owners as of the record date (for more information on the record date, see &ldquo;&mdash;Who is entitled to vote
at the Annual Meeting?&rdquo;).&nbsp;&nbsp;The mailing of the Notice to our stockholders is scheduled to begin on or about April
29, 2016.&nbsp;&nbsp;All stockholders will have the ability to access the proxy materials and our Annual Report on Form 10-K for
the fiscal year ended September 30, 2015 (the &ldquo;<I>Annual Report</I>&rdquo;) on a website referred to in the Notice or to
request to receive a printed set of the proxy materials and the Annual Report.&nbsp;&nbsp;Instructions on how to access the proxy
materials over the Internet or to request a printed copy may be found in the Notice.&nbsp;&nbsp;Stockholders may also request to
receive proxy materials and our Annual Report in printed form by mail or electronically by email on an ongoing basis.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">How do I get electronic access to the proxy materials?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Notice will provide you with instructions
regarding how you can:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>View our proxy materials for the Annual Meeting and our Annual Report on the Internet; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Instruct us to send our future proxy materials to you electronically by email.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Choosing to receive your future proxy materials
by email will save us the cost of printing and mailing documents to you, and will reduce the impact of printing and mailing these
materials on the environment.&nbsp;&nbsp;Stockholders may also request to receive proxy materials and our Annual Report in printed
form by mail or electronically by email on an ongoing basis. If you choose to receive future proxy materials by email, you will
receive an email next year with instructions containing a link to those materials and a link to the proxy voting website.&nbsp;&nbsp;Your
election to receive proxy materials by email will remain in effect until you terminate it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">What is the purpose of the Annual Meeting?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At our Annual Meeting, stockholders will
act upon the matters outlined in the notice of meeting accompanying this Proxy Statement, consisting of (i) the election of six
directors, (ii) the approval, on a non-binding, advisory basis, of the compensation of the Company&rsquo;s named executive officers,
and&nbsp;&nbsp;(iii) the ratification of the appointment of Marcum&nbsp;LLP as our independent registered public accounting firm
for the fiscal year ending September 30, 2016 and (iv) such other business that may properly come before the meeting.&nbsp;&nbsp;In
addition, management will report on our performance during the fiscal year ended September 30, 2015 and more recent developments
and respond to questions from stockholders.&nbsp;&nbsp;Our Board of Directors is not currently aware of any other matters which
will come before the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">How do proxies work and how are votes counted?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board of Directors is asking for your
proxy.&nbsp;&nbsp;Giving us your proxy means that you authorize us to vote your shares at the Annual Meeting in the manner you
direct.&nbsp;&nbsp;You may vote for all of our director nominees or withhold your vote as to some or all of our director nominees.&nbsp;&nbsp;You
may vote for or against, or abstain from voting on, the approval, on a non-binding, advisory basis, of the compensation of the
Company&rsquo;s named executive officers. You may also vote for or against, or abstain from voting on, the ratification of our
selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2016. If
a stockholder of record does not indicate instructions with respect to one or more matters on his, her or its proxy, the shares
represented by that proxy will be voted as recommended by the Board of Directors (for more information, see &ldquo;&mdash;What
are the Board of Directors&rsquo; recommendations as to the proposals to be voted on?&rdquo;). If a beneficial owner of shares
held in street name does not provide instructions to the bank, broker, or other nominee holding those shares, please see the information
below under the caption &ldquo;&mdash;What if I am a beneficial owner and do not give voting instructions to my broker?&rdquo;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Who is entitled to vote at the Annual Meeting?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Only stockholders of record at the close
of business on April 11, 2016, the record date for the meeting, are entitled to receive notice of and to participate in the Annual
Meeting, or any postponements and adjournments of the meeting.&nbsp;&nbsp;If you were a stockholder of record on that date, you
will be entitled to vote all of the shares you held on that date at the meeting, or any postponements or adjournments of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 11, 2016, the record date for the
meeting, there were 24,075,092 shares of common stock outstanding.&nbsp;&nbsp;Each outstanding share of common stock is entitled
to one vote on each of the matters presented at the Annual Meeting or postponements and adjournments of the meeting.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">What constitutes a quorum?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The presence at the meeting, in person or
by proxy, of the holders of a majority of the outstanding shares of common stock as of the record date will constitute a quorum,
permitting the Annual Meeting to conduct its business.&nbsp;&nbsp;As of the record date, 24,075,092 shares of common stock, representing
the same number of votes, were outstanding.&nbsp;&nbsp;Thus, the presence of holders representing at least 12,037,547 shares will
be required to establish a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If a stockholder abstains from voting as
to any matter or matters, the shares held by such stockholder shall be deemed present at the Annual Meeting for purposes of determining
a quorum.&nbsp;&nbsp;If a bank, broker, or other nominee returns a &ldquo;broker non-vote&rdquo; proxy,&rdquo; indicating a lack
of voting instructions by the beneficial holder of the shares and a lack of discretionary authority on the part of the bank, broker,
or other nominee to vote on a particular matter, then the shares covered by such broker non-vote proxy shall be deemed present
at the Annual Meeting for purposes of determining a quorum, but otherwise shall have no effect except as to any proposal with respect
to which the bank, broker, or other nominee has discretionary authority to vote the proxy. For more information on discretionary
and non-discretionary matters, see &ldquo;&mdash;What if I am a beneficial owner and do not give voting instructions to my broker?&rdquo;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">How do I attend the Annual Meeting?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The meeting will be held on June 8, 2016,
beginning at 10:00&nbsp;a.m., local time, at the Center of Excellence in Wireless and Information Technology, Stony Brook, New
York 11794. Directions to the Center of Excellence in Wireless and Information Technology can be found on our website at <I>www.adnas.com</I>.
The information found on, or accessible through, our website is not incorporated into, and does not form a part of, this Proxy
Statement or any other report or document we file with or furnish to the SEC due to the inclusion of our website address above
or elsewhere in this Proxy Statement. Information on how to vote in person at the Annual Meeting is discussed below under the caption
&ldquo;&mdash;How can I vote my shares?&rdquo; Each stockholder who wishes to attend the Annual Meeting will be required to present
valid government-issued photo identification to be admitted to the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">How can I vote my shares?</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">In person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Record stockholders:</I> Shares held in your name as the stockholder of record may be voted by you in person at the Annual
Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Owners of shares held beneficially in street name:</I> Shares held beneficially in street name may be voted by you in person
at the Annual Meeting only if you obtain a legal proxy from the broker, bank, or other nominee that holds your shares giving you
the right to vote the shares and you bring that legal proxy with you to the Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Even if you plan to attend the Annual
Meeting, we recommend that you also submit your proxy or voting instructions as described below so that your vote will be counted
if you later decide not to attend the meeting.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>By proxy:</I></B>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Whether you hold shares directly as the
stockholder of record or beneficially in street name, you may direct how your shares are voted without attending the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Record stockholders:</I> (1) You can vote by proxy over the Internet by following the instructions provided in the
                                                                                                             Notice up until 11:59 P.M. Eastern Time on June 7, 2016. (2) You can vote by telephone up until 11:59 P.M. Eastern Time on
                                                                                                             June 7, 2016 by following instructions provided on the proxy card attached to the Proxy Statement. (3) If you have requested
                                                                                                             to receive printed proxy materials, you can vote by mail by following instructions provided on the proxy card attached to the
                                                                                                             Proxy Statement.&nbsp;&nbsp;The proxy card, if you choose to vote by mail, must be received prior to the holding of the vote
                                                                                                             at the Annual Meeting at 10:00 AM, Eastern Time, on June 8, 2016.&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Owners of shares held beneficially in street name:</I> Please refer to the voting instructions provided by your broker,
bank, or other nominee for information on how to vote by telephone, by Internet or by mail. In addition, you may request paper
copies of the Proxy Statement and proxy card from your broker by following the instructions provided by your broker, bank, or other
nominee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stockholders who submit a proxy by Internet
or telephone need <B><I>not</I></B> return a proxy card or any form forwarded by your broker, bank, trust or nominee. Stockholders
who submit a proxy through the Internet or telephone should be aware that they may incur costs to access the Internet or telephone,
such as usage charges from telephone companies or Internet service providers, and that these costs must be borne by the stockholder.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">What am I voting on at the Annual Meeting?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are three matters scheduled for a
vote at the Annual Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><I>Proposal No. 1</I></B>: to elect six directors, constituting the entire Board of Directors, to serve until the Company&rsquo;s
next annual meeting of stockholders or until their respective successors are duly elected and qualified;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><I>Proposal No. 2</I></B>: to approve, on a non-binding, advisory basis, the compensation of the Company&rsquo;s named executive
officers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><I>Proposal No. 3</I></B>: to ratify the appointment of Marcum LLP as our independent registered public accounting firm
for the fiscal year ending September 30, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each of these proposals is described in
further detail below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">What happens if additional matters are presented
at the Annual Meeting?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Other than the three items of business described
in this Proxy Statement, we are not currently aware of any other business to be acted upon at the Annual Meeting.&nbsp;&nbsp;If
you grant a proxy, the persons named as proxy holders, Ms. Debbie Bailey and Ms. Beth Jantzen, or either of them, will have the
discretion to vote your shares on any additional matters properly presented for a vote at the meeting.&nbsp;&nbsp;If for any reason
any of the nominees is not available as a candidate for director, the persons named as proxy holders will vote your proxy for such
other candidate or candidates as may be nominated by the Board of Directors.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">How does the Board of Directors&rsquo; recommend
that I vote?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As to the proposals to be voted on at the
Annual Meeting, the Board of Directors unanimously recommends that you vote:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><I>FOR</I></B> Proposal No. 1, for the election of each of the six nominated candidates for director;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><I>FOR</I></B> Proposal No. 2, for the approval, on a non-binding, advisory basis, of the compensation of the Company&rsquo;s
named executive officers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><I>FOR</I></B> Proposal No. 3, for the ratification of the appointment of Marcum LLP as our independent registered public
accounting firm for the fiscal year ending September&nbsp;30, 2016.</TD></TR></TABLE>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">What if I am a stockholder of record and do not
indicate voting instructions on my proxy?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If you are a stockholder of record and provide
specific instructions on your proxy with regard to certain items, your shares will be voted as you instruct on such items.&nbsp;&nbsp;<B><I>If
no instructions are indicated on your proxy</I></B> for one or more of the proposals to be voted on, the shares will be voted as
recommended by the Board of Directors:&nbsp;&nbsp;(i) in favor of each of our director nominees, (ii) for the approval, on a non-binding,
advisory basis, of the compensation of the Company&rsquo;s named executive officers and (iii) for the ratification of Marcum LLP
as our independent registered public accounting firm for the fiscal year ending September 30, 2016.&nbsp;&nbsp;If any other matters
are properly presented for consideration at the meeting, the individuals named as proxy holders, Ms. Debbie Bailey and Ms. Beth
Jantzen, will vote the shares that they represent on those matters as recommended by the Board of Directors.&nbsp;&nbsp;If the
Board of Directors does not make a recommendation, then they will vote in accordance with their best judgment.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">What if I am a beneficial owner and do not give
voting instructions to my broker or other nominee?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a beneficial owner, in order to ensure
your shares are voted in the way you would like, you must provide voting instructions to your bank, broker, or other nominee by
the deadline provided in the materials you receive from your bank, broker, or other nominee or vote by mail, telephone or Internet
according to instructions provided by your bank, broker, or other nominee.&nbsp;&nbsp;<B><I>If you do not provide voting instructions</I></B>
to your bank, broker, or other nominee, whether your shares can be voted by such person or entity depends on the type of item being
considered for vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><I>Non-Discretionary Items</I></B>.&nbsp;&nbsp;The election of directors and the non-binding, advisory approval of the compensation
of the Company&rsquo;s named executive officers are non-discretionary items and may not be voted on by brokers, banks or other
nominees who have not received specific voting instructions from beneficial owners. A broker non-vote occurs when a broker holding
shares for a beneficial owner does not vote on a particular proposal because the broker does not have discretionary voting authority
and has not received voting instructions from the beneficial owner.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B><I>Discretionary Items</I></B>.&nbsp;&nbsp;The ratification of the appointment of Marcum LLP as our independent registered
public accounting firm for the fiscal year ending September 30, 2016 is a discretionary item.&nbsp;&nbsp;Generally, brokers, banks
and other nominees that do not receive voting instructions from beneficial owners may vote on this proposal in their discretion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>We encourage you to provide instructions
to your broker regarding the voting of your shares.</I></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Can I change my vote or revoke my proxy?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Yes.&nbsp;&nbsp;(1) If you are a stockholder
of record, you may revoke your proxy by (i) following the instructions on the Notice and entering a new vote by telephone or over
the Internet up until 11:59 P.M. Eastern Time on June 7, 2016, (ii) attending the Annual Meeting and voting in person (although
attendance at the Annual Meeting will not in and of itself revoke a proxy) or (iii) entering a new vote by mail.&nbsp;&nbsp;Any
written notice of revocation or subsequent proxy card must be received by the Secretary of the Company prior to the holding of
the vote at the Annual Meeting at 10:00 AM, Eastern Time, on June 8, 2016.&nbsp;&nbsp;Such written notice of revocation or subsequent
proxy card should be hand delivered to the Secretary of the Company or sent to the Company&rsquo;s principal executive offices
at 50 Health Sciences Drive, Stony Brook, New York 11790, Attention: Corporate Secretary.&nbsp;(2) If a broker, bank, or other
nominee holds your shares, you must contact them in order to find out how to change your vote.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>The last proxy or vote that we receive
from you will be the vote that is counted.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Who will bear the cost of soliciting votes for the
Annual Meeting?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will pay the entire cost of preparing,
assembling, printing, mailing, and distributing these proxy materials and soliciting votes.&nbsp;&nbsp;If you choose to access
the proxy materials and/or vote over the Internet, you are responsible for Internet access charges you may incur.&nbsp;&nbsp;If
you choose to vote by telephone, you are responsible for telephone charges you may incur.&nbsp;&nbsp;In addition to the mailing
of these proxy materials, the solicitation of proxies or votes may be made in person, by telephone, or by electronic communication
by our directors, officers, and employees, who will not receive any additional compensation for such solicitation activities.&nbsp;&nbsp;We
have engaged Kingsdale Shareholder Services to assist in soliciting proxies on our behalf. Kingsdale Shareholder Services&nbsp;may
solicit proxies personally, electronically or by telephone. We have agreed to pay Kingsdale Shareholder Services a fee of $9,000
for its services. We have also agreed to reimburse Kingsdale Shareholder Services for its reasonable out-of-pocket expenses and
to indemnify Kingsdale Shareholder Services and its employees against certain liabilities arising from or in connection with the
engagement.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">What is &ldquo;householding&rdquo; and where can
I get additional copies of proxy materials?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For information about householding and how
to request additional copies of proxy materials, please see the section captioned &ldquo;Householding of Proxy Materials.&rdquo;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Whom may I contact if I have other questions about
the Annual Meeting or voting?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You may contact the Company at 50 Health
Sciences Drive, Stony Brook, New York 11790, Attention: Debbie Bailey, or by telephone at 631-240-8800.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Where can I find the voting results of the Annual
Meeting?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will announce preliminary voting results
at the Annual Meeting.&nbsp;&nbsp;Voting results will be disclosed on a Form 8-K filed with the SEC within four business days after
the Annual Meeting, which will also be available on our website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We encourage you to vote by proxy
over the Internet by following the instructions provided in the Notice, or, if you requested to receive printed proxy materials,
you can also vote by mail or telephone pursuant to instructions provided on the proxy card.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_002"></A>PROPOSAL NO. 1&mdash;<BR>
ELECTION OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Six directors (constituting the entire Board
of Directors) are to be elected at the Annual Meeting to serve until the 2017 Annual Meeting of Stockholders or until their respective
successors are elected and qualified.&nbsp;&nbsp;All of the nominees are our current directors and have been nominated for re-election
by our Board of Directors.&nbsp;&nbsp;The Company intends that the proxy in the form presented will be voted, unless otherwise
indicated, for the election of these nominees to serve until the 2017 Annual Meeting of Stockholders or until their successors
are elected and qualified.&nbsp;&nbsp;Our Certificate of Incorporation provides that the number of directors that constitute the
whole Board of Directors shall be fixed exclusively in the manner designated in the Company&rsquo;s Bylaws. The Company&rsquo;s
Bylaws provide that the number of directors is determined by resolution of the Board of Directors, provided that the Board of Directors
shall consist of at least one member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On July 11, 2011, Delabarta, Inc. (&ldquo;<I>Delabarta</I>&rdquo;),
a wholly owned subsidiary of ABARTA, Inc. (&ldquo;<I>ABARTA</I>&rdquo;), participated as an investor in the Company&rsquo;s private
placement of our common stock, as described in our Current Report on Form 8-K filed with the SEC on July 15, 2011.&nbsp;&nbsp;In
connection with the investment in the Company by Delabarta, we agreed to use best efforts to nominate its designee, Mr. John Bitzer,
III to the Board and elect Mr. Bitzer as a director within 30 days of the closing and to nominate and include Mr. Bitzer on the
slate of nominees for the Board of Directors for election by stockholders at the annual meetings of stockholders for so long as
Delabarta owns at least 2% of the outstanding shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Should one or more of these nominees be
unable to accept nomination or election as a director, the individuals named as proxies, Ms.&nbsp;Debbie Bailey and Ms.&nbsp;Beth
Jantzen, will vote the shares that they represent for such other persons as the Board of Directors may recommend.&nbsp;&nbsp;The
Board of Directors has no present knowledge that any of the nominees for director named below will be unavailable to serve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The directors standing for re-election,
together with their ages as of April 29, 2016 and certain other information, are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt times new roman; width: 100%">
<tr>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 20%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 2px solid">Director</P></td>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%">
</td>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 4%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Age</P></td>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%">
</td>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 8%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Year&nbsp;First<br>
        Became<br>
        Director</P></td>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%">
</td>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 65%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Principal
        Occupation and Other Board Service</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 2px solid">During the Past Five Years</P></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>James A. Hayward, Ph.D., Sc.D.</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">62</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">2005</td>
    <TD>&nbsp;</td>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr. James A. Hayward has been our Chief Executive Officer since
        March 17, 2006 and our President and the Chairman of the Board of Directors since June 12, 2007. He was previously our acting Chief
        Executive Officer since October 5, 2005. He also served as Acting Chief Financial Officer from August 20, 2013 through October
        13, 2013. Dr. Hayward received his Ph.D. in Molecular Biology from the State University of New York at Stony Brook in 1983 and
        an honorary Doctor of Science from the same institution in 2000. His experience with public companies began with the co-founding
        of one of England&rsquo;s first biotechnology companies&mdash;Biocompatibles. Following this, Dr. Hayward was Head of Product Development
        for the Estee Lauder companies for five years. In 1990 he founded The Collaborative Group, a provider of products and services
        to the biotechnology, pharmaceutical and consumer-product industries based in Stony Brook, where he served as Chairman, President
        and Chief Executive Officer for 14 years. During this period, The Collaborative Group created several businesses, including The
        Collaborative BioAlliance, a contract developer and manufacturer of human gene products that was sold to Dow Chemical in 2002,
        and Collaborative Labs, a service provider and manufacturer of ingredients for skincare and dermatology that was sold to Engelhard
        (now BASF) in 2004. Dr. Hayward also serves on the Board of Directors for the Regents Council, Softheon Corporation, NeoMatrix
        Formulations, Inc. and Ward Melville Heritage Organization.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board believes that Dr. Hayward&rsquo;s current role as
        our Chief Executive Officer and President, the capital investments he has made to the Company throughout his tenure with us and
        his former senior executive positions in our industry make him an important contributor to our Board.</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt times new roman; width: 100%">
<tr>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 20%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 2px solid">Director</P></td>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%">
</td>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 4%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Age</P></td>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%">
</td>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 8%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Year&nbsp;First<br>
        Became<br>
        Director</P></td>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%">
</td>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 65%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Principal
        Occupation and Other Board Service</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 2px solid">During the Past Five Years</P></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>John Bitzer, III</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">55</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">2011</td>
    <TD>&nbsp;</td>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John Bitzer, III, joined the Board of Directors on August 10,
        2011. Mr. Bitzer is President and Chief Executive Officer of ABARTA, a private, third and fourth generation family holding-company
        with operations in the soft drink, energy, and frozen food industries. In 1985, Mr. Bitzer began his career in sales for the Cleveland
        Coca-Cola Bottling Company. He has been Publisher of Atlantic City Magazine in Atlantic City, N.J. In 1994, he founded the ABARTA
        Media Group and held the position of Group Publisher. In 1997, he was named President and Chief Operating Officer of ABARTA and
        has been President and Chief Executive Officer since 1999. Mr. Bitzer has a degree from the University of Southern California and
        a Masters of Business Administration (&ldquo;MBA&rdquo;) from the University of Michigan.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board believes that Mr. Bitzer&rsquo;s professional and
        management experience in investing in and building growing enterprises make him an important contributor to the Board.</P></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>Joseph D. Ceccoli</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">53</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">2014</td>
    <TD>&nbsp;</td>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Joseph D. Ceccoli was appointed to the Board of Directors on
        December 3, 2014. Since 2010, Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC, a bioscience company located
        at the Stony Brook Long Island High Technology Incubator. Biocogent is focused on the invention, development and commercialization
        of skin-active molecules and treatment products used in regulated (over-the-counter / med-care), personal care and consumer products.
        Prior to starting Biocogent, Mr. Ceccoli was Global Director of Operations for BASF Corporation, a global Fortune 100 company and
        the world&rsquo;s largest global chemical company, where he was responsible for the integration, operations and growth of domestic
        and overseas business units from 2007 to 2008. Prior to BASF, Mr. Ceccoli was a General Manager for Engelhard Corporation, a US
        based fortune 500 company and chief operating officer of Long Island-based The Collaborative Group from 2004 to 2007. Mr. Ceccoli
        holds a Bachelor of Science (&ldquo;B.S.&rdquo;) degree in Biotechnology from Rochester Institute of Technology and advanced professional
        training in various pharmaceutical sciences, emulsion chemistry, engineering and management disciplines. He is a member of numerous
        professional organizations such as the American Chemical Society and the Society of Cosmetic Chemists.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board believes that Mr. Ceccoli&rsquo;s professional, operational
        and management experience make him an important contributor to our Board.</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt times new roman; width: 100%">
<tr style="vertical-align: bottom">
    <TD STYLE="width: 20%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 1.5pt solid"><br>
        Director</P></td>
    <TD STYLE="width: 1%">
</td>
    <TD STYLE="width: 4%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Age</P></td>
    <TD STYLE="width: 1%">
</td>
    <TD STYLE="width: 8%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Year&nbsp;First<br>
        Became<br>
        Director</P></td>
    <TD STYLE="width: 1%">
</td>
    <TD STYLE="width: 65%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Principal&nbsp;Occupation&nbsp;and&nbsp;Other&nbsp;Board&nbsp;Service<br>
        During&nbsp;the&nbsp;Past&nbsp;Five&nbsp;Years</P></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>Charles S. Ryan</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">51</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">2011</td>
    <TD>&nbsp;</td>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr. Charles S. Ryan joined the Board of Directors on August
        10, 2011. Since March 2015, Dr. Ryan has been Vice President and General Counsel for Cold Spring Harbor Laboratory, a preeminent
        international research institution. Prior to that, Dr. Ryan was the Senior Vice President, and Chief Intellectual Property Counsel
        at Forest Laboratories, where he was employed from 2003 to 2014. Dr. Ryan has over 20 years&rsquo; experience in managing all aspects
        of intellectual property litigation, conducting due diligence investigations and prosecuting patent and trademark applications
        in the pharmaceutical and biotechnology industries. Dr. Ryan earned a doctorate in oral biology and pathology from SUNY Stony Brook
        and a law degree from Western New England College School of Law.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board believes that Mr. Ryan&rsquo;s expertise as general
        counsel for a preeminent international research institution and former chief intellectual property counsel at a global company
        makes him an important contributor to the Board.</P></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>Yacov A. Shamash</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">66</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">2006</td>
    <TD>&nbsp;</td>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr. Yacov A. Shamash has been a member of the Board of
        Directors         since March 17, 2006. Dr. Shamash is Vice President of Economic Development at the State University of New
        York at Stony Brook.         From 1992 to 2015, he was the Dean of Engineering and Applied Sciences, and from 1995 to 2004,
        Dr. Shamash was also the Dean of         the Harriman School for Management and Policy at the University. He was founder of
        the New York State Center for Excellence in         Wireless and Information Technology at the University. Dr. Shamash
        developed and directed the NSF Industry/University Cooperative         Research Center for the Design of Analog/Digital
        Integrated Circuits from 1989 to 1992 and also served as Chairman of the Electrical         and Computer Engineering
        Department at Washington State University from 1985 until 1992. Dr. Shamash also serves on the Board of         Directors of
        Keytronic Corp.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As Vice President of Economic Development at the State University
        of New York at Stony Brook, Dr. Shamash daily encounters leaders of businesses large and small, regional and global in their reach
        and, as a member of our Board, has played an integral role in our business development by providing the highest-level introductions
        to customers, channels to market and to the media. Dr. Shamash also brings to our Board his valuable experience gained from serving
        as a director at other private and public companies.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board believes that Dr. Shamash&rsquo;s professional and
        management experience, service on other companies&rsquo; boards and education make him an important contributor to our Board.</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt times new roman; width: 100%">
<tr style="vertical-align: bottom">
    <TD STYLE="width: 20%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 1.5pt solid"><br>
        Director</P></td>
    <TD STYLE="width: 1%">
</td>
    <TD STYLE="width: 4%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Age</P></td>
    <TD STYLE="width: 1%">
</td>
    <TD STYLE="width: 8%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Year&nbsp;First<br>
        Became<br>
        Director</P></td>
    <TD STYLE="width: 1%">
</td>
    <TD STYLE="width: 65%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1.5pt solid">Principal&nbsp;Occupation&nbsp;and&nbsp;Other&nbsp;Board&nbsp;Service<br>
        During&nbsp;the&nbsp;Past&nbsp;Five&nbsp;Years</P></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>Sanford R. Simon</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">73</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">2006</td>
    <TD>&nbsp;</td>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr. Sanford R. Simon has been a member of the Board of Directors
        since March 17, 2006. Dr. Simon has been a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook since 1997. He
        joined the faculty at Stony Brook as an Assistant Professor in 1969 and was promoted to Associate Professor with tenure in 1975.
        Dr. Simon was a member of the Board of Directors of The Collaborative Group from 1995 to 2004. From 1967 to 1969, Dr. Simon was
        a Guest Investigator at Rockefeller University. Dr. Simon received a B.A. in Zoology and Chemistry from Columbia University in
        1963, a Ph.D. in Biochemistry from Rockefeller University in 1967, and studied as a postdoctoral fellow with Nobel Prize winner
        Max Perutz in Cambridge, England. He maintains an active research laboratory studying aspects of cell invasion in cancer and inflammation
        and novel strategies of drug delivery; he also teaches undergraduate, graduate, medical and dental students.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr. Simon is an expert at the use of large biomolecules in commercial
        media, and we have made use of his expertise in formulating DNA into commercial carriers for specific customers. As a member of
        our Board, Dr. Simon has advised us on patents, provided technical advice, and introduced us to corporate partners and customers.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board believes that Dr. Simon&rsquo;s professional experience,
        expertise, and education make him an important contributor to our Board.</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no family relationships between
any director, executive officer, or person nominated or chosen by us to become a director or executive officer.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vote Required</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The six nominees who receive the highest
number of affirmative votes of the shares present in person or represented by proxy and entitled to vote, a quorum being present,
will be elected as our directors.&nbsp;&nbsp;Abstentions, broker non-votes and instructions on the accompanying proxy card to withhold
authority to vote for one or more nominees will not be counted as votes in favor of the relevant nominee or nominees and will result
in the relevant nominee or nominees receiving fewer total votes.&nbsp;&nbsp;However, the number of votes cast in favor of such
nominee will not be reduced by any abstention, broker non-vote or instructions to withhold authority.&nbsp;&nbsp;The Company intends
that the proxy in the form presented will be voted, unless otherwise indicated, for the election of these nominees.&nbsp;&nbsp;In
the absence of instructions to the contrary, the shares represented by the accompanying proxy card will be voted &ldquo;FOR&rdquo;
all the nominees named above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>The Board of Directors unanimously
recommends a vote &ldquo;FOR&rdquo; the election of</I><BR>
<I>each of the nominees to the Board of Directors named in this Proposal No. 1.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_003"></A>PROPOSAL NO. 2&mdash;<BR>
NON-BINDING, ADVISORY APPROVAL OF THE COMPENSATION<BR>
OF THE COMPANY&rsquo;S NAMED EXECUTIVE OFFICERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are providing our stockholders the opportunity
to vote to approve, on a non-binding, advisory basis, the compensation of our &ldquo;named executive officers&rdquo; disclosed
in this Proxy Statement in accordance with the SEC&rsquo;s rules. This proposal, which is commonly referred to as &ldquo;say-on-pay,&rdquo;
is required under Section 14A of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), which was added
by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. As indicated in this Proxy Statement under the heading
&ldquo;Executive Compensation,&rdquo; our &ldquo;named executive officers&rdquo; for the most recently completed fiscal year consist
of our (i) President and Chief Executive Officer, (ii) Chief Financial Officer, (iii) Chief Information Officer and (iv) Secretary
and Chief Scientific Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At our 2013 annual meeting of stockholders,
the majority of stockholders voted to advise us to include a say-on-pay proposal every three years, and the Board of Directors
determined that the Company will hold an advisory say-on-pay vote every three years. The next advisory say-on-pay vote will occur
no later than the Company&rsquo;s 2019 annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our executive compensation programs are
designed to attract, motivate, and retain our executive officers, who are critical to our success, as more fully described in the
&ldquo;Executive Compensation&rdquo; section of this Proxy Statement. Under these programs, as approved by our Compensation Committee,
our named executive officers are rewarded for the achievement of our near-term and longer-term financial and strategic goals, for
driving corporate financial performance and stability and for increasing stockholder value. The programs contain elements of both
cash and equity-based compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The &ldquo;Executive Compensation&rdquo;
section beginning on page 21 describes in detail our executive compensation programs and the decisions made by our Compensation
Committee and our Board of Directors with respect to the fiscal year ended September 30, 2015. As discussed in those disclosures,
we believe that our compensation program provides a competitive overall compensation that is designed to attract and retain top
performers. To achieve this goal, our compensation program is structured to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>provide total compensation and compensation elements that are competitive with those companies that are competing for available
employees;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>hold our executive officers accountable for results over the long term and maintain integrity in all of the business dealings
of our executive officers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>align the interest of our executives with our stockholders;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reward exceptional performance by individual employees;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>provide a mix of compensation that offers (i) a meaningful base compensation, with a potential to earn additional amounts based
on achievement of corporate and personal goals, and (ii) the opportunity to share in the long-term growth of our company through
equity compensation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>establish a clear connection between rewards and performance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board believes this link between compensation
and the achievement of our near- and long-term business goals has helped drive our performance over time. At the same time, we
believe our program does not encourage excessive risk-taking by management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This proposal is not intended to address
any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies
and practices described under &ldquo;Executive Compensation.&rdquo; Our Board is asking stockholders to indicate their support
for the compensation of our named executive officers as described in this Proxy Statement by casting a non-binding, advisory vote
&ldquo;FOR&rdquo; the following resolution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>RESOLVED</B>,
that the Company&rsquo;s stockholders hereby approve, on a non-binding, advisory basis, the compensation paid to the Company&rsquo;s
named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission,
including the compensation tables and any related material disclosed in the Company&rsquo;s Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As an advisory vote, this proposal is not
binding. The outcome of this advisory vote will not affect any compensation already paid or awarded to any named executive officer
and does not overrule any decision by us or our Board of Directors (or any committee thereof) or create or imply any change to
our fiduciary duties or the fiduciary duties of our Board of Directors (or any committee thereof). However, our Compensation Committee
and Board of Directors value the opinions expressed by our stockholders in their vote on this proposal and will consider the outcome
of the vote when making future compensation decisions for named executive officers.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vote Required</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The affirmative vote of a majority of the
outstanding shares of our Common Stock present in person or represented by proxy at the Annual Meeting and entitled to vote is
required for the approval of Proposal No. 2. Broker non-votes, if any, with respect to this matter will be treated as neither a
vote &ldquo;for&rdquo; nor a vote &ldquo;against&rdquo; the matter and will not be counted in determining the number of votes necessary
for approval (although they will be counted in determining if a quorum is present). However, abstentions will be considered in
determining the total number of votes required to attain a majority of the shares present in person or represented by proxy at
the meeting entitled to vote. Accordingly, an abstention from voting by a stockholder present in person or represented by proxy
at the meeting has the same legal effect as a vote &ldquo;against&rdquo; the matter because it represents a share present in person
or represented by proxy at the meeting and entitled to vote, thereby increasing the number of affirmative votes required to approve
this proposal. It is intended that the proxy in the form presented will be voted, unless otherwise indicated, &ldquo;FOR&rdquo;
Proposal No. 2. If no instructions are indicated, the shares will be voted &ldquo;FOR&rdquo; Proposal No. 2.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>The Board of Directors unanimously
recommends that stockholders vote to approve, on a non-binding,<BR>
 advisory basis, the compensation of our named executive officers
by voting &ldquo;FOR&rdquo; Proposal No. 2.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_004"></A>PROPOSAL NO. 3&mdash;<BR>
RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC<BR>
ACCOUNTING FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board of Directors has appointed Marcum
LLP (&ldquo;<I>Marcum</I>,&rdquo; the &ldquo;<I>principal accountant</I>&rdquo; or the &ldquo;<I>independent accountant</I>&rdquo;)
as the independent registered public accounting firm to audit our consolidated financial statements as of and for the fiscal year
ending September 30, 2016. Marcum has been our independent registered public accounting firm since it was appointed on June 23,
2014 to audit our consolidated financial statements for the fiscal year ended September 30, 2014. Since that date, Marcum has also
provided us certain tax and other audit-related services. The Board has directed that management submit the selection of our independent
registered public accounting firm for ratification by the stockholders at the Annual Meeting. Representatives of Marcum LLP are
expected to be present at the Annual Meeting, in person or telephonically, will have an opportunity to make a statement if they
so desire, and will be available to respond to appropriate questions. Notwithstanding its selection, the Board of Directors, in
its discretion, may appoint another independent registered public accounting firm at any time during the year if the Board of Directors
believes that such a change would be in our and our stockholders&rsquo; best interests.&nbsp;&nbsp;If the appointment is not ratified
by our stockholders, the Board of Directors may reconsider whether it should appoint another independent registered public accounting
firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">RBSM LLP (&ldquo;RBSM&rdquo;) served as
our independent registered public accounting firm for the fiscal years ended September 30, 2013 and September 30, 2012. For more
information, see &ldquo;Proposal No. 3&mdash;Ratification of Appointment of Independent Registered Accounting Firm&mdash;Change
in Independent Registered Public Accounting Firm&rdquo; in our Proxy Statement filed with the SEC on May 6, 2015. We do not expect
that a representative from RBSM will be present at the Annual Meeting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Audit and Other Fees</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth fees billed
to us by our current and former independent auditors during the fiscal years ended September 30, 2015 and 2014 for: (i) services
rendered for the audit of our annual financial statements and the review of our quarterly financial statements, (ii) services by
our auditor that are reasonably related to the performance of the audit or review of our financial statements and that are not
reported as Audit Fees, (iii) services rendered in connection with tax compliance, tax advice and tax planning, and (iv) all other
fees for services rendered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.38in">
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td><b><i>RBSM LLP</i></b> (1)</td>
    <td>&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <TD COLSPAN="3" NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD COLSPAN="2" NOWRAP STYLE="border-bottom: black 1.5pt solid; text-align: center">Fiscal year<br>
ended <br>
September<br>
30, 2015</td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD COLSPAN="2" NOWRAP STYLE="border-bottom: black 1.5pt solid; text-align: center">Fiscal year<br>
ended <br>
September<br>
30, 2014</td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD STYLE="width: 7%">(i)</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 46%">Audit Fees</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 1%">$</td>
    <TD STYLE="width: 20%; text-align: right">207,908</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 1%">$</td>
    <TD STYLE="width: 20%; text-align: right">98,500</td>
    <TD STYLE="width: 1%">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>(ii)</td>
    <td>&nbsp;</td>
    <td>Audit Related Fees</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">37,000</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td>(iii)</td>
    <td>&nbsp;</td>
    <td>Tax Fees</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">7,000</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">(iv)</td>
    <td style="padding-bottom: 1.5pt">&nbsp;</td>
    <td style="padding-bottom: 1.5pt">All Other Fees</td>
    <td style="padding-bottom: 1.5pt">&nbsp;</td>
    <td style="border-bottom: black 1.5pt solid">&nbsp;</td>
    <td style="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">&mdash;</td>
    <td style="padding-bottom: 1.5pt">&nbsp;</td>
    <td style="padding-bottom: 1.5pt">&nbsp;</td>
    <td style="border-bottom: black 1.5pt solid">&nbsp;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&mdash;</td>
    <td style="padding-bottom: 1.5pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td colspan="3">Total Fees</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">207,908</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">142,500</td>
    <td>&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: 0.38in">
<tr style="vertical-align: bottom">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD><b><i>Marcum LLP</i></b> (2)</td>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <TD COLSPAN="3" NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD COLSPAN="2" NOWRAP STYLE="border-bottom: black 1.5pt solid; text-align: center">Fiscal year<br>
ended <br>
September 30,<br>
2015</td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD COLSPAN="2" NOWRAP STYLE="border-bottom: black 1.5pt solid; text-align: center">Fiscal year ended <br>
September 30, 2014</td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD STYLE="width: 7%">(i)</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 46%">Audit Fees</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 1%">$</td>
    <TD STYLE="width: 20%; text-align: right">230,424</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 1%">$</td>
    <TD STYLE="width: 20%; text-align: right">104,000</td>
    <TD STYLE="width: 1%">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>(ii)</td>
    <TD>&nbsp;</td>
    <TD>Audit Related Fees</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">8,788</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&mdash;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD>(iii)</td>
    <TD>&nbsp;</td>
    <TD>Tax Fees</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">8,240</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&mdash;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-bottom: 1.5pt">(iv)</td>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD STYLE="padding-bottom: 1.5pt">All Other Fees</td>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</td>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-bottom: 1.5pt; text-align: right">&mdash;</td>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</td>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right">&mdash;</td>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td colspan="3">Total Fees</td>
    <TD>&nbsp;</td>
    <TD>$</td>
    <TD STYLE="text-align: right">247,452</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>$</td>
    <TD STYLE="text-align: right">104,000</td>
    <TD>&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RBSM served as our independent auditors through
June 23, 2014<BR>
(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marcum has served as our current independent auditors since June 23, 2014</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Audit Fees</I> &mdash; Consists of fees billed for professional
services rendered for the audit of our consolidated financial statements, review of the interim consolidated financial statements
included in quarterly reports, and services that are normally provided by our independent auditors in connection with statutory
and regulatory filings or engagements, including registration statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Audit Related Fees</I> &mdash; Consists of fees billed for
assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial
statements and are not reported under &ldquo;Audit Fees,&rdquo; such as accounting consultation and audits in connection with acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Tax Fees</I> &mdash; Consists of fees billed for professional
services for tax compliance, tax advice and tax planning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>All Other Fees</I> &mdash; Consists of fees for products
and services other than the services reported above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board of Directors has considered whether
the provision of non-audit services is compatible with maintaining the principal accountant&rsquo;s independence.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Change in Independent Registered Public Accounting Firm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Effective June 23, 2014, we appointed Marcum
as our independent registered public accounting firm for the fiscal year ending September 30, 2014, and dismissed RBSM&nbsp;as
our independent registered public accounting firm. Both actions were approved by our Audit Committee. As described below, the change
in independent registered public accounting firms was not the result of any disagreement with RBSM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The reports issued by RBSM with respect
to our consolidated financial statements for the fiscal years ended September 30, 2013 and 2012 did not contain an adverse opinion
or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the fiscal years ended September
30, 2013 and 2012 (and the subsequent interim periods preceding RBSM&rsquo;s dismissal), there were no disagreements between us
and RBSM on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which
disagreement(s), if not resolved to the satisfaction of RBSM, would have caused RBSM to make reference to the subject matter of
the disagreement(s) in connection with its report(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the fiscal years ended September
30, 2013 and 2012, there were no &ldquo;reportable events&rdquo; (as defined in Item 304(a)(1)(v) of Regulation S-K), except that
in RBSM&rsquo;s report dated May 1, 2014 (which was included in our 2013 Form 10-K/A) on&nbsp;&nbsp;our internal control over financial
reporting as of September 30, 2013, RBSM expressed an adverse opinion on the effectiveness of our internal control over financial
reporting due to the existence of the material weakness identified and described in &ldquo;Management&rsquo;s Report on Internal
Control Over Financial Reporting&rdquo; under Item 9A in our fiscal year ended September 30, 2013 Form 10-K/A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As required by Item 304(a)(3) of Regulation
S-K, we furnished a copy of the above disclosures to RBSM and requested that RBSM furnish us with a letter addressed to the SEC
stating whether RBSM agrees with the above statements. A copy of RBSM&rsquo;s letter to the SEC, dated June 25, 2014, is filed
as Exhibit 16.1 to our&nbsp;Current Report on Form 8-K dated June 23, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No consultations occurred between us and
Marcum during the two most recent fiscal years and the subsequent interim periods prior to Marcum&rsquo;s appointment regarding
either (i) the application of accounting principles to a specific completed or contemplated transaction, the type of audit opinion
that might be rendered on our financial statements, or other information provided that was considered by us in reaching a decision
as to an accounting, auditing or financial reporting issue, or (ii) any matter that was the subject of disagreements (as defined
in Item 304(a)(1)(iv) of Regulation S-K) or a reportable event (as defined in Item 304(a)(1)(v) of Regulation S-K).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Audit Committee Report</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The audit committee of the Board of Directors
(the &ldquo;<I>audit committee</I>&rdquo;) operates under a written charter approved by the Board of Directors, which provides
that its responsibilities include the oversight of the Company&rsquo;s accounting and financial reporting processes and the audits
of its financial statements and assisting the Board of Directors in monitoring the integrity of the Company&rsquo;s financial statements,
the qualifications and independence of the Company&rsquo;s independent auditors, the performance of the Company&rsquo;s internal
audit function and independent auditors and the compliance by the Company with legal and regulatory requirements. For more information
on the audit committee, see &ldquo;Management and Corporate Governance&mdash;Board of Directors Structure and Committee Composition&mdash;Audit
Committee.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The audit committee oversees the Company&rsquo;s
financial reporting process on behalf of the Board of Directors.&nbsp;&nbsp;Management is responsible for the Company&rsquo;s internal
controls, financial reporting process, and compliance with laws and regulations and ethical business standards.&nbsp;&nbsp;Marcum&nbsp;is
responsible for performing an independent audit of the Company&rsquo;s consolidated financial statements for the fiscal year ending
September 30, 2016 in accordance with the standards of the Public Company Accounting Oversight Board (United States) (the &ldquo;<I>PCAOB</I>&rdquo;).&nbsp;&nbsp;The
audit committee&rsquo;s main responsibility is to monitor and oversee this process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The audit committee reviewed and discussed
our audited consolidated financial statements as of and for the fiscal year ended September 30, 2015 with management.&nbsp;&nbsp;The
audit committee discussed with Marcum&nbsp;the matters required to be discussed by Statement on Auditing Standards No. 61, as amended
(Communication with Audit Committees) (AICPA, Professional Standards, Vol. 1. AU section 380), as adopted by the PCAOB in Rule
3200T.&nbsp;&nbsp;The audit committee has received the written disclosures and the letter from the independent accountant required
by applicable requirements of the PCAOB regarding the independent accountant&rsquo;s communications with the audit committee concerning
independence, and has discussed with the independent accountant the independent accountant&rsquo;s independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The audit committee considered any fees
paid to Marcum&nbsp;for the provision of non-audit related services and does not believe that these fees compromised Marcum&rsquo;s&nbsp;independence
in performing the audit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on the review and discussions referred
to above in this report, the audit committee recommended to the Board of Directors that such audited financial statements be included
in the Company&rsquo;s Annual Report on Form 10-K for the year ended September 30, 2015 for filing with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</td>
    <TD STYLE="width: 45%">THE AUDIT COMMITTEE</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>John Bitzer, III (Chairperson)</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>Charles Ryan</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>Yacov Shamash</td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Policy on Audit Committee Pre-Approval of Audit and Permissible
Non-Audit Services of Independent Auditors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The audit committee has adopted a policy
and procedures for the pre-approval of audit and non-audit services provided by the independent auditors. These services may include
audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year
and any pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget.
The independent auditors and management are required to periodically report to our audit committee regarding the extent of services
provided by the independent auditors in accordance with this pre-approval, and the fees for the services performed to date. The
audit committee may also pre-approve particular services on a case-by-case basis.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vote Required</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The affirmative vote of a majority of the
outstanding shares of our common stock present in person or represented by proxy at the Annual Meeting and entitled to vote is
required for the ratification of the appointment of Marcum&nbsp;as our independent registered public accounting firm for the fiscal
year ending September 30, 2016.&nbsp;&nbsp;Abstentions will be considered in determining the total number of votes required to
attain a majority of the shares present in person or represented by proxy at the meeting entitled to vote.&nbsp;&nbsp;Accordingly,
an abstention from voting by a stockholder present in person or represented by proxy at the meeting has the same legal effect as
a vote &ldquo;against&rdquo; the matter because it represents a share present in person or represented by proxy at the meeting
and entitled to vote, thereby increasing the number of affirmative votes required to approve this proposal.&nbsp;&nbsp;The ratification
of the appointment of Marcum as our independent registered public accounting firm for the fiscal year ending September 30, 2016
is a discretionary item. Brokers, banks, and other nominees that do not receive voting instructions from beneficial owners of our
common stock may generally vote on this proposal in their discretion. The Company intends that the proxy in the form presented
will be voted, unless otherwise indicated, for the ratification of Marcum.&nbsp;&nbsp;If no instructions are indicated, the shares
will be voted &ldquo;FOR&rdquo; the ratification of Marcum&nbsp;as our auditors for the fiscal year ending September 30, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B><I>The Board of Directors
deems Proposal No. 3 &ldquo;Ratification of Appointment of Independent Registered Accounting Firm&rdquo; to be in our and our stockholders&rsquo;
best interests and unanimously recommends a vote &ldquo;FOR&rdquo; approval thereof.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_005"></A>MANAGEMENT AND CORPORATE
GOVERNANCE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Information Regarding the Board of Directors</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Members</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board of Directors currently consists
of six members:&nbsp;&nbsp;James A. Hayward, John Bitzer, III, Joseph D. Ceccoli, Charles S. Ryan, Yacov A. Shamash and Sanford
R. Simon.&nbsp;&nbsp;Our Board of Directors has nominated the six incumbent directors for re-election at the Annual Meeting.&nbsp;&nbsp;Please
see &ldquo;Proposal&nbsp;No. 1&mdash;Election of Directors&rdquo; for the names, ages and business experience of each of the Company&rsquo;s
director nominees for election at the Annual Meeting.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Director Independence</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board of Directors has determined that
currently and at all times during the fiscal year ended September 30, 2015, each of our directors other than Dr. Hayward&mdash;consisting
of John Bitzer, III, Joseph D. Ceccoli, Charles S. Ryan, Yacov A. Shamash and Sanford R. Simon&mdash;are and were &ldquo;independent&rdquo;
as defined by the listing standards of The NASDAQ Stock Market LLC (&ldquo;Nasdaq&rdquo;), constituting a majority of independent
directors on our Board of Directors as required by the rules of Nasdaq.&nbsp;&nbsp;The Board of Directors considers in its evaluation
of independence whether any director has a relationship with us that would interfere with the exercise of independent judgment
in carrying out his or her responsibilities of a director.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board Leadership Structure and Role in Risk Oversight</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board of Directors does not have a policy
on whether the same person should serve as both the Chief Executive Officer and Chairman of the Board or, if the roles are separate,
whether the Chairman should be selected from the non-employee directors or should be an employee. The Board of Directors believes
that Dr. Hayward&rsquo;s dual role as both Chairman of the Board and Chief Executive Officer serves the best interests of both
us and our stockholders. His combined role enables decisive leadership, ensures clear accountability, and enhances our ability
to communicate our message and strategy clearly and consistently to our stockholders, employees, customers and suppliers. Dr. Hayward
possesses detailed and in-depth knowledge of the issues, opportunities and challenges facing us and our business and is thus best
positioned to develop agendas that ensure that the time and attention of the Board of Directors are focused on the most critical
matters. This structure also enables our Chief Executive Officer to act as a bridge between management and the Board of Directors,
helping both to act with a common purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board of Directors appreciates that
the advantages gained by having a single Chairman and Chief Executive Officer must be viewed in light of potential independence
concerns. The Board considers, however, that we have adequate safeguards in place to address those concerns, including, for example,
our Board of Directors consisting of a supermajority of independent directors. In addition, our audit, compensation and nominating
committees, which oversee critical matters such as the integrity of our financial statements, the compensation of executive management,
the selection and evaluation of directors, and the development and implementation of corporate governance policies, each consist
entirely of independent directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our risk management program is overseen
by our Chief Executive Officer. Material risks are identified and prioritized by management, and each prioritized risk is referred
to a Board committee or the full Board of Directors for oversight. For example, strategic risks are referred to the full Board
while financial risks are referred to the audit committee. The Board of Directors regularly reviews information regarding our liquidity
and operations, as well as the risks associated with each. Also, the compensation committee periodically reviews the most important
risks to our business to ensure that compensation programs do not encourage excessive risk-taking and promote our goals and objectives.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors Structure and Committee Composition</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2008, our Board of Directors
established a standing compensation committee (the &ldquo;compensation committee&rdquo;) and in September 2011, our Board of
Directors established an audit committee and a nominating committee (the &ldquo;nominating committee&rdquo;). Each of the
committees operates under a written charter adopted by the Board of Directors. All of the committee charters are available on
our web site at <I>www.adnas.com/company-charter</I> or by writing to Applied DNA Sciences, Inc., 50 Health Sciences Drive,
Stony Brook, New York 11790, c/o Investor Relations. The information found on, or accessible through, our website is not
incorporated into, and does not form a part of, this Proxy Statement or any other report or document we file with or furnish
to the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During fiscal 2015, the Board of
Directors held eight formal meetings (including regularly scheduled and special meetings) and acted by unanimous written
consent seven times. During fiscal 2015, each director attended at least 75% of all meetings of the Board of Directors and of
all meetings of the committee or committees on which he served. Directors are strongly encouraged to attend our annual
meetings of stockholders. 100% of directors then serving on the Board of Directors attended the Company&rsquo;s annual
meeting of stockholders held in 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The membership of each of the audit committee,
the compensation committee, and the nominating committee is composed, and was composed during the fiscal year ended September 30,
2015, entirely of independent directors. In addition, the members of the audit committee meet the heightened standards of independence
for audit committee members required by SEC rules and NASDAQ rules. The committee membership and the responsibilities of each of
the committees during the fiscal year ended September 30, 2015 are described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: Black 2px solid"><b>Name</b></td>
    <TD>&nbsp;</td>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Audit</b></td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Compensation</b></td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Nominating</b></td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td style="width: 61%">James A. Hayward</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 9%; text-align: center">&mdash;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 12%; text-align: center">&mdash;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 9%; text-align: center">&mdash;</td>
    <td style="width: 1%">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>John Bitzer, III (I)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><img src="pg21.jpg"></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><img src="pg21a.jpg"></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><img src="pg21a.jpg"></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td>Joseph D. Ceccoli (I)(1)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&mdash;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>Charles S. Ryan (I)(1)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><img src="pg21a.jpg"></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><img src="pg21a.jpg"></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&mdash;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td>Sanford R. Simon (I)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><img src="pg21a.jpg"></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>Yacov A. Shamash (I)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><img src="pg21a.jpg"></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><img src="pg21.jpg"></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><img src="pg21.jpg"></td>
    <td>&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt"><img src="pg21.jpg"></FONT></TD>
    <TD STYLE="width: 96%; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">Chairperson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><img src="pg21a.jpg"></FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">Member</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>(I)</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">Independent director</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) Effective March 2016, Mr. Ceccoli was appointed a member
of the Compensation Committee. Mr. Ryan no longer serves on the Compensation Committee, effective March 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Audit Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Messrs. Bitzer (Chairperson), Ryan and Shamash
served during the fiscal year ended September 30, 2015, and currently continue to serve, on the audit committee. The Board of Directors
has determined that each member of the audit committee is independent within the meaning of the director independence standards
of the company and NASDAQ as well as the heightened director independence standards of the SEC for audit committee members, including
Rule 10A-3(b)(1) under the Exchange Act. The Board of Directors has also determined that each of the members of the audit committee
is financially sophisticated and is able to read and understand consolidated financial statements and that Mr. Bitzer is an &ldquo;audit
committee financial expert&rdquo; as defined in the Exchange Act. During fiscal 2015, the audit committee held four formal meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The composition and responsibilities of
the audit committee and the attributes of its members, as reflected in the charter, are intended to be in accordance with applicable
requirements for corporate audit committees. The audit committee charter will be reviewed, and amended if necessary, on an annual
basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The audit committee assists the Board of
Directors in fulfilling its oversight responsibility relating to our financial statements and the disclosure and financial reporting
process, our system of internal controls, our internal audit function, the qualifications, independence and performance of our
independent registered public accounting firm, compliance with our code of ethics and legal and regulatory requirements. The audit
committee has the sole authority to appoint, retain, terminate, compensate and oversee the work of the independent registered public
accounting firm, as well as to pre-approve all audit and non-audit services to be provided by the independent registered public
accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Compensation Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Messrs. Bitzer, Shamash (Chairperson) and
Ryan served on the compensation committee during the fiscal year ended September 30, 2015. Effective March 2016, the membership
of the compensation committee consists of Mr. Bitzer, Mr. Shamash (Chairperson) and Joseph D. Ceccoli. The compensation committee
reviews and approves salaries and bonuses for all officers, administers options outstanding under our stock incentive plan, provides
advice and recommendations to the Board regarding directors&rsquo; compensation and carries out the responsibilities required by
SEC rules. The compensation committee believes that its processes and oversight should be directed toward attracting, retaining
and motivating employees and non-employee directors to promote and advance our interests and strategic goals. As requested by the
compensation committee, the Chief Executive Officer will provide information and may participate in discussion regarding compensation
for other executive officers. The compensation committee does not utilize outside compensation consultants but considers other
general industry information and trends if available. During fiscal 2015, the compensation committee held four formal meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B><I>Nominating Committee</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Messrs. Shamash (Chairperson), Bitzer
and Simon served during the fiscal year ended September 30, 2015, and currently continue to serve, on the nominating
committee. The Board of Directors has determined that each member of the nominating committee is independent within the
meaning of the director independence standards of the Company, NASDAQ and the SEC. During fiscal 2015, the nominating
committee did not hold any formal meetings and acted by unanimous written consent one time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The nominating committee is responsible
for, among other things: reviewing Board composition, procedures and committees, and making recommendations on these matters to
the Board of Directors; and reviewing, soliciting and making recommendations to the Board of Directors and stockholders with respect
to candidates for election to the Board.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Process for Identifying and Evaluating Nominees
for the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Director Qualifications</I>.</B> The
nominating committee has not formally established any specific, minimum qualifications that must be met by each candidate for the
Board of Directors or specific qualities or skills that are necessary for one or more of the members of the Board of Directors
to possess.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Identifying Nominees</I>.</B> The
nominating committee has two primary methods for identifying director candidates (other than those proposed by our stockholders,
as discussed below). First, on a periodic basis, the nominating committee will solicit ideas for possible candidates from a number
of sources, including members of the Board of Directors, our executive officers and individuals personally known to the members
of the Board of Directors. Second, the nominating committee is authorized to use its authority under its charter to retain at our
expense one or more search firms to identify candidates (and to approve such firms&rsquo; fees and other retention terms).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Stockholder Candidates</I>.</B> The
nominating committee will consider candidates for nomination as a director submitted by stockholders. Although the nominating committee
does not have a separate policy that addresses the consideration of director candidates recommended by stockholders, the Board
of Directors does not believe that such a separate policy is necessary because our bylaws permit stockholders to nominate candidates
and one of the duties set forth in the nominating committee charter is to consider director candidates submitted by stockholders
in accordance with our bylaws. The nominating committee will evaluate individuals recommended by stockholders for nomination as
directors according to the criteria discussed above and in accordance with our bylaws and the procedures described under &ldquo;Stockholder
Proposals and Nominations&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Review of Director Nominees.</I></B>
The nominating committee will evaluate any candidates recommended by stockholders against the same criteria and pursuant to the
same policies and procedures applicable to the evaluation of candidates proposed by our directors, executive officers, third-party
search firms or other sources. In evaluating proposed director candidates, the nominating committee may consider, in addition to
any minimum qualifications and other criteria for Board of Directors membership approved by the Board of Directors from time to
time, all facts and circumstances that it deems appropriate or advisable, including, among other things, the proposed director
candidate&rsquo;s understanding of the our business and industry on a technical level, his or her judgment and skills, his or her
depth and breadth of professional experience or other background characteristics, his or her independence, his or her willingness
to devote the time and effort necessary to be an effective board member, and the needs of the Board of Directors. We do not have
a formal policy with regard to the consideration of diversity in identifying director nominees. However, the Board of Directors
believes that it is essential that its members represent diverse viewpoints, with a broad array of experiences, professions, skills,
geographic representation and backgrounds that, when considered as a group, provide a sufficient mix of perspectives to allow the
Board of Directors to best fulfill its responsibilities to the long-term interests of our stockholders. The nominating committee
considers at least annually, and recommends to the Board of Directors suggested changes to, if any, the size, composition, organization
and governance of the Board of Directors and its committees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Stockholder Proposals and Nominations</I>.
</B>In order for a stockholder to nominate a person for election as a director at the 2016 Annual Meeting of stockholders, you
must provide written notice to Applied DNA Sciences, Inc., 50 Health Sciences Drive, Stony Brook, New York 11790, c/o Corporate
Secretary. The Corporate Secretary must receive this notice within the time period specified in the proxy statement for the 2015
annual meeting of stockholders. The notice of a proposed director nomination must provide information and documentation as required
in our bylaws which, in general, require that the notice of a director nomination include the information about the nominee that
would be required to be disclosed in the solicitation of proxies for the election of a director under federal securities laws;
the nominee&rsquo;s written consent to be named in the proxy statement as a nominee and to serve as a director if elected; a description
of any transaction or arrangement during the last three years between the stockholder making the nomination and the nominee in
which the nominee had a direct or indirect material interest; and a completed and signed questionnaire, representation and agreement.
A copy of the bylaw requirements will be provided upon request to the Corporate Secretary at the address above.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stockholder Communications with the Board</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stockholders and other interested parties
may make their concerns known confidentially to the Board of Directors or the independent directors by submitting a communication
in an envelope addressed to the &ldquo;Board of Directors,&rdquo; a specifically named independent director or the &ldquo;Independent
Directors&rdquo; as a group, in care of the Corporate Secretary. All such communications will be conveyed, as applicable, to the
full Board of Directors, the specified independent director or the independent directors as a group.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Code of Ethics</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board of Directors adopted a &ldquo;code
of ethics&rdquo; as defined by regulations promulgated under the Securities Act and the Exchange Act (our &ldquo;<I>Code of Business
Conduct and Ethics</I>&rdquo;) that applies to all of our employees, officers and directors, including those officers responsible
for financial reporting. The Code of Business Conduct and Ethics is designed to codify the ethical standards that we believe are
reasonably designed to deter wrong-doing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have established procedures to ensure
that suspected violations of the Code of Business Conduct and Ethics may be reported anonymously. A current copy of our Code of
Business Conduct and Ethics is available on our website at <I>www.adnas.com/code-conduct</I>. A copy may also be obtained, free
of charge, from us upon a request directed to Applied DNA Sciences, Inc., 50 Health Sciences Drive, Stony Brook, New York 11790,
c/o Investor Relations. We intend to disclose any amendments to or waivers of a provision of the Code of Business Conduct and Ethics
granted to directors and officers by posting such information on our website available at <I>www.adnas.com</I> and/or in our public
filings with the SEC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Executive Officers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our current executive officers, and their
ages and positions as of April 29, 2016, are set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Dr. James A. Hayward</I></B>, age
62, has been our Chief Executive Officer since March 17, 2006 and our President and the Chairman of the Board of Directors since
June 12, 2007. He was previously our acting Chief Executive Officer since October 5, 2005. He also served as Acting Chief Financial
Officer from August 20, 2013 through October 13, 2013. Dr. Hayward received his Ph.D. in Molecular Biology from the State University
of New York at Stony Brook in 1983 and an honorary Doctor of Science from the same institution in 2000. His experience with public
companies began with the co-founding of one of England&rsquo;s first biotechnology companies&mdash;Biocompatibles. Following this,
Dr. Hayward was Head of Product Development for the Estee Lauder companies for five years. In 1990 he founded The Collaborative
Group, a provider of products and services to the biotechnology, pharmaceutical and consumer-product industries based in Stony
Brook, where he served as Chairman, President and Chief Executive Officer for 14 years. During this period, The Collaborative Group
created several businesses, including The Collaborative BioAlliance, a contract developer and manufacturer of human gene products,
that was sold to Dow Chemical in 2002, and Collaborative Labs, a service provider and manufacturer of ingredients for skincare
and dermatology that was sold to Engelhard (now BASF) in 2004. Dr. Hayward also serves on the Board of Directors for the Regents
Council, Softheon Corporation, NeoMatrix Formulations Inc. and Ward Melville Heritage Organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Beth Jantzen</I></B>, age 39, was
appointed as our Chief Financial Officer, effective February 15, 2015. Ms. Jantzen held the position of Controller since May 2013.
Prior to joining the Company, Ms. Jantzen was a senior manager at Marcum LLP, our independent registered accounting firm since
June 23, 2014, where she managed multiple engagements and specialized in SEC policies, practices and procedures, including Sarbanes-Oxley
compliance. Ms. Jantzen holds a B.S. in Accounting from the State University of New York at Binghamton and is also a Certified
Public Accountant (CPA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Ms. Judith Murrah</I></B>, age 57,
has been our Chief Information Officer since June 1, 2013. Ms. Murrah is responsible for information technology strategy and implementation.
Ms. Murrah comes to us from Motorola Solutions, which had acquired her former firm, Symbol Technologies. She was Senior Director
of Information Technology, overseeing global IT program management office, financial and supplier operations and quality assurance.
At Symbol, Ms. Murrah held leadership positions in product line management, global account sales, corporate and marketing communications
and IT. Ms. Murrah holds an MBA from Harvard Business School, and a B.S. in Industrial Engineering from the University of Rhode
Island. She is an author on eleven U.S. patents and one additional pending. Ms. Murrah is co-founder and President of non-profit
ConnectToTech, a recognized leader in engaging students in science, technology, engineering and math disciplines. Ms. Murrah was
named to 2005 and 2006 Top 50 Women of Long Island and received the inaugural 2001 Diamond Award for Long Island Women Leaders
in Technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Dr. Ming-Hwa Benjamin Liang</I></B>,
age 54, has been our Secretary and Chief Scientific Officer since October 2005. Between May 1999 and September 2005, Dr. Liang
was the director of research and development at Biowell Technology Inc. Dr. Liang received a B.S. in Bio-Agriculture from Colorado
State University in 1989, a Masters of Science in Horticulture from the University of Missouri at Columbia in 1991, a Ph.D. in
Plant Science from the University of Missouri at Columbia in 1997 and an LL.M. in Intellectual Property Law from Shih Hsin University,
Taiwan in 2004.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our executive officers are elected by, and
serve at the discretion of, our Board of Directors. There are no family relationships between any director, executive officer,
or person nominated or chosen by us to become a director or executive officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_006"></A>EXECUTIVE COMPENSATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Compensation Overview</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our compensation approach is necessarily
tied to our stage of development as a company. We are principally devoted to developing DNA embedded biotechnology security solutions
and to date, have had a limited operating history. As a company with a limited operating history, we have necessarily limited the
establishment of extensive administrative and operating infrastructure, and a formal executive compensation policy has not been
established. We have a compensation committee of the Board of Directors that is responsible for all compensation matters of our
Chief Executive Officer. The compensation of all our other named executive officers is approved by our Board of Directors upon
the recommendation of our compensation committee, which in turn relied upon the recommendation of our Chief Executive Officer.
As discussed below, the recommendation of our Chief Executive Officer is largely discretionary, based on his subjective assessment
of the particular executive. As we continue to grow, we expect that the specific direction, emphasis and components of our executive
compensation program will continue to evolve. The compensation committee has overall responsibility for approving and evaluating
our executive officers&rsquo; compensation plans, policies and programs. Our compensation program is designed to employ best practices
in executive compensation and consider all relevant regulatory guidance regarding sound incentive compensation policies. The remainder
of this section provides a general summary of our compensation policies and procedures.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Executive Compensation Philosophy and Objectives</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">General</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The fundamental purpose of our executive
compensation program is to assist us in achieving our financial and operating performance objectives. Specifically, we attempt
to tailor an executive&rsquo;s compensation to (1) retain and motivate the executive, (2) reward him or her upon the achievement
of company-wide, and individual performance, and (3) align the executive&rsquo;s interest with the creation of long-term stockholder
value, without encouraging excessive risk taking. To that end, and within the context of the stage of our company, we have compensated
our named executive officers through a mix of base salary, equity-based incentives, and cash bonuses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our business model is based on our ability
to establish long-term relationships with clients and to maintain our strong mission, client focus, entrepreneurial spirit and
team orientation. We have sought to create an executive compensation package that balances short-term versus long-term components
when considering cash bonuses and employee options, in ways we believe are most appropriate to motivate senior management and reward
them for achieving the following goals:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Develop a culture that embodies a commitment for our business, creative contribution and a drive to achieve established goals
and performance objectives;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Provide leadership to the organization in such a way as to maximize the results of our business operations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Lead us by demonstrating forward thinking in the operation, development and expansion of our business;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Effectively manage organizational resources to derive the greatest value possible from each dollar invested; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Take strategic advantage of the market opportunity to expand and grow our business and revenues.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe that having a compensation program
designed to align executive officers to meet our business objectives and to reinforce excellent performance and accountability
is the cornerstone to successfully implement and achieve our strategic plan. In determining the compensation of our executive officers,
we are guided by the following key principles:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Competition</I>. Compensation should reflect the competitive marketplace, so we can retain, attract and motivate talented
executives.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Accountability for Business Performance</I>. Compensation should be tied to financial performance, so that executives are
held accountable through their compensation for contributions to the performance of our company as a whole as well as their performance
of the business unit for which they are responsible.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Accountability for Individual Performance</I>. Compensation should be tied to the individual&rsquo;s performance to encourage
and reflect individual contributions to our company&rsquo;s performance. We consider individual performance as well as performance
of the business and responsibility areas that an individual oversees, and weigh these factors as appropriate in assessing a particular
individual&rsquo;s performance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Alignment with Stockholder Interests</I>. Compensation should be tied to our financial performance through equity awards
to align executives&rsquo; interests with those of our stockholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our executive compensation structure not
only aims to be competitive in our industry, but also to be fair relative to compensation paid to other professionals within our
organization, relative to our short-term and long-term performance and relative to the value we deliver to our stockholders. We
seek to maintain a performance-oriented culture and a compensation approach that rewards our executive officers when we achieve
our goals and objectives, while putting at risk an appropriate portion of their compensation against the possibility that our goals
and objectives may not be achieved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Chief Executive Officer is the only
named executive officer with an employment agreement. In addition, there are no change in control, severance or noncompetition
agreements with any other named executive officer, nor are we otherwise obligated to pay any named executive officers any amounts
if there is a change in control of the Company or if such executive&rsquo;s employment with us terminates, except for the Chief
Executive Officer, as described below in the section entitled &ldquo;&mdash;Potential Payments upon Termination of Employment or
a Change of Control.&rdquo;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Determination of Executive Compensation Awards</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The compensation committee establishes and
monitors the basic philosophy governing the compensation of the Chief Executive Officer. On an annual basis, the compensation committee
reviews and makes recommendations to the Board of Directors with respect to the compensation of the Chief Executive Officer including
incentive compensation plans and equity-based plans. Currently, compensation decisions for all other of our executive officers
are approved by our Board of Directors upon the recommendation of our compensation committee, which in turn relied upon the recommendation
of our Chief Executive Officer. We have traditionally placed significant emphasis on the recommendation of our Chief Executive
Officer with respect to the determination of executive compensation (other than his own), in particular with respect to the determination
of base salary, cash incentive and equity incentive awards, and typically followed such recommendations as presented by our Chief
Executive Officer. As we continue to grow, we will make the transition to have our compensation committee be solely responsible
for administering our executive compensation program, although we expect to continue to rely, in part, upon the advice and recommendations
of our Chief Executive Officer (other than with respect to his own compensation), particularly with respect to those executive
officers that report directly to him. The compensation committee&rsquo;s composition and oversight of our executive compensation
program is described in more detail below in the section entitled &ldquo;&mdash;Compensation Committee.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For purposes of determining our executive
officer compensation in the fiscal year ended September 30, 2015 and in prior fiscal years, we considered the following factors:
our understanding of the amount of compensation generally paid by similarly situated companies to their executives with similar
roles and responsibilities; the roles and responsibilities of our executives; the individual experience and skills of, and expected
contributions from, our executives; the amounts of compensation being paid to our other executives; our executives&rsquo; historical
compensation at our company; an assessment of the professional effectiveness and capabilities of the executive officer; and the
performance of the executive officer against the corporate and other scorecards used to determine incentive compensation. While
we have not used any formula or formal benchmarking to determine compensation based on these factors, we have placed the most emphasis
in determining compensation on our understanding of the amount of compensation generally paid by similarly situated companies to
their executives with similar roles and responsibilities and the subjective assessment of the professional effectiveness and capabilities
of the executive officer. Our understanding of the amount of compensation generally paid by similarly situated companies was based
on our compensation committee&rsquo;s and our Chief Executive Officer&rsquo;s own business judgment and collective experience in
such matters.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Base Salary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board of Directors sets the Chief Executive
Officer&rsquo;s base salary annually in accordance with the terms of his employment agreement, based on the recommendation of the
compensation committee (provided that any change by the Board of Directors may increase, but not decrease, the Chief Executive
Officer&rsquo;s annual rate of base salary). Dr. Hayward&rsquo;s annual base salary was voluntarily reduced in fiscal 2014 and
fiscal 2015 and Dr. Hayward also deferred the amount of $50,000 subject to repayment under certain conditions. For more information,
see &ldquo;&mdash;Employment Agreement with Dr. James A. Hayward.&rdquo; The base salary for each of the other named executive
officers is reviewed annually by the Chief Executive Officer and any adjustments are approved by the compensation committee. Adjustments
to base salary are based upon a review of a variety of factors, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>individual and Company performance, measured against quantitative and qualitative goals, such as our growth, revenue, profitability
and other matters;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>duties and responsibilities as well as the executive&rsquo;s experience; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the types and amount of each element of compensation to be paid to the named executive officer.</TD></TR></TABLE>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash Bonuses</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Chief Executive Officer is paid cash
bonuses in accordance with the terms of his employment agreement as well as based on the discretion of the compensation committee
and approval by the Board of Directors. We pay discretionary cash bonuses to our other named executive officers, which are recommended
by the Chief Executive Officer. The cash bonuses, if any, which are determined after the end of each fiscal year and may be paid
annually, are intended to recognize and reward those named executive officers who have contributed meaningfully to our performance
for the prior year. Both personal and the Company&rsquo;s performance are factors that the Board of Directors and Chief Executive
Officer typically consider in deciding whether to award a cash bonus to a named executive officer and the amount of such bonus.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Long-term Stock-Based Compensation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our long-term compensation program has historically
consisted solely of stock options. Option grants made to executive officers are designed to provide them with incentive to execute
their responsibilities in such a way as to generate long-term benefit to us and our stockholders. Through possession of stock options,
our executives participate in the long-term results of their efforts, whether by appreciation of our Company&rsquo;s value or the
impact of business setbacks, either company-specific or industry-based. Additionally, stock options provide a means of ensuring
the retention of our executive officers, in that they are in most cases subject to vesting over an extended period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock options provide executives with a
significant and long-term interest in our success. By only rewarding the creation of stockholder value, we believe stock options
provide our executive officers with an effective risk and reward profile. Although it is our current practice to use stock options
as our sole form of long-term incentive compensation, the compensation committee reviews this practice on an annual basis in light
of our overall business strategy, existing market-competitive best practices and other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock options are granted periodically and
are subject to vesting based on the executive&rsquo;s continued employment. Historically we have granted our executive officers
a combination of incentive stock options that vest over a period of time or stock options that are immediately exercisable. Most
options vest evenly over four years, beginning on the anniversary of the date of the grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock options are granted to our executive
officers in amounts determined by the compensation committee in its discretion. Stock grants have not been formula-based, but instead
have historically been granted taking into account a mixture of the following qualitative factors: the executive&rsquo;s level
of responsibility; the competitive market for the executive&rsquo;s position; the executive&rsquo;s potential contribution to our
growth; and the subjective assessment of the professional effectiveness and capabilities of these executives.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Benefits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We provide the following benefits to our
executive officers on the same basis as the benefits provided to all employees:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>health and dental insurance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>life insurance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>short-and long-term disability; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>401(k) Plan (currently there is no employer matching)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">These benefits are generally consistent
with those offered by other companies and specifically with those companies with which we compete for employees.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Summary Compensation Table</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth the compensation
of our principal executive officer, our principal financial officer and our other executive officers for the fiscal years ended
September 30, 2015, 2014 and 2013. We refer to these executive officers as our &ldquo;named executive officers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <TD NOWRAP STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font-size: 8pt"><B>Year</B></FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font-size: 8pt"><B>Salary</B><br>
    <B>($)&nbsp;(c)</B></FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font-size: 8pt"><B>Bonus</B><br>
    <B>($)&nbsp;(d)</B></FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font-size: 8pt"><B>Stock</B><br>
    <B>Awards</B><br>
    <B>($)&nbsp;(e)</B></FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font-size: 8pt"><B>Option</B><br>
    <B>Awards</B><br>
    <B>($)&nbsp;(f)&nbsp;(1)</B></FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font-size: 8pt"><B>Non-Equity</B><br>
    <B>Incentive&nbsp;Plan</B><br>
    <B>Compensation</B><br>
    <B>($)&nbsp;(g)</B></FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font-size: 8pt"><B>Change&nbsp;in</B><br>
    <B>Pension&nbsp;Value</B><br>
    <B>and</B><br>
    <B>Nonqualified</B><br>
    <B>Deferred</B><br>
    <B>Compensation</B><br>
    <B>Earnings</B><br>
    <B>($)&nbsp;(h)</B></FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font-size: 8pt"><B>All&nbsp;Other</B><br>
    <B>Compensation</B><br>
    <B>($)&nbsp;(i)</B></FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><FONT STYLE="font-size: 8pt"><B>Total</B><br>
    <B>($)&nbsp;(j)</B></FONT></td>
    <TD NOWRAP STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD STYLE="width: 24%"><FONT STYLE="font-size: 8pt">James A. Hayward</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 7%; text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">311,538</FONT></td>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 8pt">(2)&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">375,000</FONT></td>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 8pt">(3)&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">706,025</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">1,392,563</FONT></td>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 8pt"><I>Chairman, President</I></FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2014</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">343,269</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">3,530,437</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">3,873,706</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 8pt"><I>and CEO</I>(6)</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2013</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">319,974</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">150,000</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">469,974</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD><FONT STYLE="font-size: 8pt">Beth M. Jantzen</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">209,615</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">22,500</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;(7)</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">194,806</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">426,921</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 8pt"><I>CFO</I>(4)</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2014</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2013</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD><FONT STYLE="font-size: 8pt">Judith Murrah</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">240,385</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">25,000</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;(8)</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">186,525</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">451,910</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 8pt"><I>CIO</I>(5)</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2014</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">250,000</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">195,691</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">445,691</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2013</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">81,731</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">81,731</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD><FONT STYLE="font-size: 8pt">Ming-Hwa Benjamin Liang</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">2015</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">140,000</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">5,000</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;(9)</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">320,540</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">465,540</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="background-color: azure">
    <TD STYLE="vertical-align: bottom; padding-left: 9pt"><FONT STYLE="font-size: 8pt"><I>Chief Scientific Officer and Secretary</I>(6)</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 8pt">2014<br>
    2013</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 8pt">140,000<br>
    140,000</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 8pt">2,000<br>
    10,000</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;<br>
    &mdash;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 8pt">211,826<br>
    &mdash;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;<br>
    &mdash;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;<br>
    &mdash;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;<br>
    &mdash;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 8pt">353,826<br>
    150,000</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 8%; text-align: center">(1)</td>
    <td style="width: 92%">The amounts in column (f) represent the grant date fair value calculated in accordance with ASC 718 based on the Black Scholes value of the options on the grant date. Information concerning these amounts and the assumptions used to calculate these amounts are set forth in our Form 10-K for the fiscal year ended September 30, 2015 filed with the SEC on December 14, 2015 under the caption &ldquo;Item 7. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations &mdash;Equity Based Compensation.&rdquo; </td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 8%; padding-right: 0.8pt; text-align: center">(2)</td>
    <td style="width: 92%; padding-right: 0.8pt">$50,000 of Mr. Hayward&rsquo;s base salary for fiscal 2015 as reported in this column was deferred and will be repaid if and when the Company attains certain performance targets. For more information, see &ldquo;&mdash;Employment Agreement with Dr. James A. Hayward.&rdquo;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 0.8pt">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; text-align: center">(3)</td>
    <td>As a result of the Company&rsquo;s revenue exceeding $9 million for the fiscal year ending September 30, 2015, Dr. Hayward earned a bonus of $375,000, in accordance with the terms of his employment agreement.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 8%; text-align: center">(4)</td>
    <td style="width: 92%">Ms. Jantzen was appointed as Chief Financial Officer effective February 15, 2015.&nbsp;&nbsp;Ms. Jantzen&rsquo;s annual base salary was $225,000 during fiscal 2015 and she received 30,000 options upon becoming CFO. </td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 8%; text-align: center">(5)</td>
    <td style="width: 92%; text-align: justify">Ms. Murrah&rsquo;s annual base salary is $250,000.&nbsp;&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 8%; text-align: center">(6)</td>
    <td style="width: 92%; text-align: justify">Dr. Hayward and Dr. Liang had the terms for 166,667 options extended for an
    additional five years, that were set to originally expire on June 30, 2015.&nbsp;&nbsp;The term of each of these options was
    extended to a total of 10 years for consistency with our current compensation practices, in which employee stock options are
    generally granted for a term of 10 years. This resulted in stock based compensation expense of $270,800 for each of them and
    is included in the table above. Each amount represents the grant date fair value under ASC 718 based on the Black Scholes
    value of the options on the grant date. Information concerning these amounts and the assumptions used to calculate these
    amounts are set forth in our Form 10-K for the fiscal year ended September 30, 2015 filed with the SEC on December 14, 2015
    under the caption &ldquo;Item 7. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations
    &mdash;Equity Based Compensation.&rdquo;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">(7)</td>
    <td style="text-align: justify">Ms. Jantzen (i) was paid a $10,000 cash bonus during fiscal 2015 prior to her becoming CFO on February 15, 2015 and (ii) earned a cash bonus of $12,500 for fiscal 2015, which was paid during fiscal 2016.</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">(8)</td>
    <td style="text-align: justify">Ms. Murrah earned a cash bonus of $25,000 for fiscal 2015, which was paid during fiscal 2016.</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">(9)</td>
    <td style="text-align: justify">Dr. Liang earned a cash bonus of $5,000 for fiscal 2015, which was paid during fiscal 2016.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Grants of Plan-Based Awards</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table provides information
regarding grants of plan-based awards to our named executive officers during the fiscal year ended September 30, 2015:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <TD NOWRAP STYLE="border-bottom: Black 2px solid"><br>
<b>Name</b></td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Grant</b><br>
<b>Date</b></td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>All Other</b><br>
<b>Stock</b><br>
<b>Awards:</b><br>
<b>Number of</b><br>
<b>Shares of</b><br>
<b>Stock or</b><br>
<b>Units (1)</b><br>
<b>(#)</b></td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>All Other</b><br>
<b>Option</b><br>
<b>Awards:</b><br>
<b>Number of</b><br>
<b>Securities</b><br>
<b>Underlying</b><br>
<b>Options</b><br>
<b>(#)</b></td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Exercise or</b><br>
<b>Base Price of</b><br>
<b>Option</b><br>
<b>Awards</b><br>
<b>($/Sh)</b></td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Grant Date</b><br>
<b>Fair Value of</b><br>
<b>Stock and</b><br>
<b>Option</b><br>
<b>Awards (4)</b><br>
<b>($)</b></td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <td style="width: 21%">James A. Hayward</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 14%; text-align: right">12/22/2014</td>
    <td style="width: 4%"><font style="font-size: 10pt"><sup>(1)</sup></font></td>
    <td style="width: 1%; text-align: right">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 13%; text-align: right">&mdash;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 11%; text-align: right">175,000</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">$</td>
    <td style="width: 11%; text-align: right">2.86</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">$</td>
    <td style="width: 12%; text-align: right">435,225</td>
    <td style="width: 1%">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">6/30/2015</td>
    <td><font style="font-size: 10pt"><sup>(2)</sup></font></td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">166,667</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">3.60</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">270,800</td>
    <td>&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <td>Beth Jantzen</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12/22/2014</td>
    <td nowrap><font style="font-size: 10pt"><sup>(1)(5)</sup></font></td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">40,000</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">2.86</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">99,480</td>
    <td>&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">2/15/2015</td>
    <td><font style="font-size: 10pt"><sup>(3)</sup></font></td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">30,000</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">3.45</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">95,326</td>
    <td>&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <td>Judith Murrah</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12/22/2014</td>
    <td><font style="font-size: 10pt"><sup>(1)</sup></font></td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">75,000</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">2.86</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">186,525</td>
    <td>&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <td>Ming-Hwa Benjamin Liang</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12/22/2014</td>
    <td><font style="font-size: 10pt"><sup>(1)</sup></font></td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">20,000</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">2.86</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">49,740</td>
    <td>&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">6/30/2015</td>
    <td><font style="font-size: 10pt"><sup>(2)</sup></font></td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">166,667</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">3.60</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">270,800</td>
    <td>&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Options are exercisable for ten years and vested immediately.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>On June 30, 2015, Dr. Hayward and Dr. Liang had the terms for 166,667 options extended for an additional five years that
                                                            were set to originally expire on June 30, 2015. The term of each of these options was extended to a total of 10 years for
                                                            consistency with our current compensation practices, in which employee stock options are generally granted for a term of 10
                                                            years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>Options are exercisable for five years with vesting at 25% each anniversary over four years from the date of grant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>These amounts represent the grant date fair value calculated in accordance with ASC 718 based on the Black Scholes value
                                                            of the options on the grant date. Information concerning these amounts and the assumptions used to calculate these amounts
                                                            are set forth in our Form 10-K for the fiscal year ended September 30, 2015 filed with the SEC on December 14, 2015 under the
                                                            caption &ldquo;Item 7. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations
                                                            &mdash;Equity Based Compensation.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(5)</TD><TD>These options were granted to Ms. Jantzen for her service as Controller prior to her appointment as the Chief Financial Officer.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Outstanding Equity Awards at Fiscal Year-End</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table shows information concerning
outstanding equity awards as of September 30, 2015 held by the named executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD COLSPAN="13" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Option Awards</b></td></tr>
<tr style="vertical-align: bottom">
    <TD NOWRAP STYLE="border-bottom: Black 2px solid"><b>Name</b></td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Number of</b><br>
<b>Securities</b><br>
<b>Underlying</b><br>
<b>Unexercised</b><br>
<b>Options</b><br>
<b>(#)</b><br>
<b>Exercisable</b></td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Number of</b><br>
<b>Securities</b><br>
<b>Underlying</b><br>
<b>Unexercised</b><br>
<b>Options</b><br>
<b>(#)</b><br>
<b>Unexercisable</b></td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Option</b><br>
<b>Exercise</b><br>
<b>Price</b><br>
<b>($)</b></td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: center; border-bottom: Black 2px solid"><b>Option</b><br>
<b>Expiration</b><br>
<b>Date</b></td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td style="width: 44%">James A. Hayward</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 10%; text-align: right">166,667</td>
    <td style="width: 4%">(5)</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 12%; text-align: right">&mdash;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 9%; text-align: right">3.60</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 12%; text-align: right">6/30/2020</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">666,667</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">3.51</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">7/11/2018</td></tr>
<tr style="background-color: azure">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">208,334</td>
    <td>(1)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">625,000</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">5.82</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">10/16/2018</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">175,000</td>
    <td>(6)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">2.86</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12/21/2024</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD NOWRAP>Beth M. Jantzen</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">1,042</td>
    <TD NOWRAP>(3)(7)</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">3,125</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">5.31</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">10/31/2018</td></tr>
<tr style="background-color: white">
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">1,042</td>
    <TD NOWRAP>(3)(8)</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">3,125</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">6.96</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">11/28/2018</td></tr>
<tr style="background-color: white">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">4,167</td>
    <td>(3)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">8.16</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12/09/2018</td></tr>
<tr style="background-color: white">
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">40,000</td>
    <TD NOWRAP>(3)(6)</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">&mdash;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">2.86</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="text-align: right">12/21/2024</td></tr>
<tr style="background-color: white">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>(4)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">30,000</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">3.45</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">2/14/2025</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td>Judith Murrah</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">8,334</td>
    <td>(2)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">25,000</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">7.02</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12/01/2018</td></tr>
<tr style="background-color: azure">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">75,000</td>
    <td>(6)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">2.86</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12/21/2024</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">4,167</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">8.16</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12/09/2018</td></tr>
<tr style="background-color: white">
    <td>Ming-Hwa Benjamin Liang</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">166,667</td>
    <td>(5)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">3.60</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">6/30/2020</td></tr>
<tr style="background-color: white">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12,500</td>
    <td>(1)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">37,500</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">5.82</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">10/16/2018</td></tr>
<tr style="background-color: white">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">20,000</td>
    <td>(6)</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">2.86</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">12/21/2024</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>On October 17, 2013, we granted Dr. James A. Hayward, and Dr. Ming-Hwa Benjamin Liang options to purchase 833,334 and 50,000
shares of our common stock, respectively, at an exercise price of $5.82 per share for five years with vesting at 25% each anniversary
for the next four years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>On December 2, 2013, we granted 33,334 options to purchase our common stock at an exercise price of $7.02 per share for five
years to Ms. Murrah with vesting at 25% each anniversary for the next four years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>These options were granted to Ms. Jantzen for her service as Controller prior to her appointment as the Chief Financial Officer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>We granted 30,000 options to purchase our common stock at an exercise price of $3.45 per share for ten years to Ms. Jantzen,
effective February 15, 2015, with vesting at 25% each anniversary for the next four years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(5)</TD><TD>On June 30, 2015, Dr. Hayward and Dr. Liang had the term of each of these options extended for an additional five years
                                                            that were set to originally expire on June 30, 2015. The term of each of these options was extended to a total of 10 years
                                                            for consistency with our current compensation practices, in which employee stock options are generally granted for a term of
                                                            10 years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(6)</TD><TD>On December 22, 2014, we granted an aggregate of 610,000 options to purchase our common stock at an exercise price of $2.86
per share for ten years to employees, with immediate vesting. As part of this grant, Dr. Hayward, Ms. Jantzen, Ms. Murrah, and
Dr. Liang were granted 175,000, 40,000, 75,000 and 20,000 options, respectively.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(7)</TD><TD>25% of these options will vest and become exercisable each anniversary over four years, commencing on October 14, 2014, one
year from the date of grant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(8)</TD><TD>25% of these options will vest and become exercisable each anniversary over four years, commencing on November 29, 2014, one
year from the date of grant.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Option Exercises and Stock Vested</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the fiscal year ended September 30,
2015, none of our named executive officers exercised options or acquired shares upon vesting of stock awards.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pension Benefits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of our named executive officers participates
in or has account balances in qualified or non-qualified defined benefit plans sponsored by us.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nonqualified Contribution Plans</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of our named executive officers participates
in or has account balances in non-qualified defined contribution plans maintained by us.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deferred Compensation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of our named executive officers participates
in or has account balances in deferred compensation plans or arrangements, except for Dr. Hayward as set forth below under the
caption &ldquo;Employment Agreement with Dr. James A. Hayward.&rdquo;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employment Agreement with Dr. James A. Hayward</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>The following is a discussion of our
employment agreement with Dr. Hayward as of September 30, 2015 and, where indicated, compensation actions prior to such date. For
compensation actions&nbsp;subsequent to the end of our most recently completed fiscal year, see &ldquo;&mdash;Executive Compensation
Actions Taken in Fiscal 2016 (through April 19th).&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We entered into an employment agreement
dated July 11, 2011, with Dr. James A. Hayward, our Chairman, President and Chief Executive Officer. The agreement provides that
Dr. Hayward will be our Chief Executive Officer, and will continue to serve on our Board of Directors. The initial term of his
employment was from July 1, 2011 through June 30, 2014, which automatically renews for one-year periods subject to ninety days&rsquo;
prior notice of non-renewal by either party. Pursuant to contract, Dr. Hayward&rsquo;s annual salary is $350,000. The Board of
Directors, acting in its discretion, may grant annual bonuses to Dr. Hayward. Dr. Hayward will be eligible for a special cash incentive
bonus of up to $750,000, 40% of which will be payable if and when annual revenue reaches $6 million and 10% of which would be payable
for each $2 million of annual revenue in excess of $6 million. As a result of the Company&rsquo;s revenue exceeding $9 million
for the fiscal year ended September 30, 2015, Dr. Hayward earned a bonus of $375,000 for the fiscal year ended September 30, 2015
in accordance with the terms of his employment agreement. Dr. Hayward will be entitled to certain benefits and perquisites and
will be eligible to participate in retirement, welfare and incentive plans available to our other employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The agreement with Dr. Hayward also provides
that if he is terminated before the end of the initial or a renewal term by us without cause or if Dr. Hayward terminates his employment
for &ldquo;good reason&rdquo; (as defined in his employment agreement), then, in addition to previously earned and unpaid salary,
bonus and benefits, and subject to the delivery of a general release and continuing compliance with restrictive covenants, Dr.
Hayward will be entitled to receive a pro rata portion of the greater of either (X) the annual bonus he would have received if
employment had continued through the end of the year of termination or (Y) the prior year&rsquo;s bonus; salary continuation payments
for two years following termination equal to the greater of (i) three times base salary or (ii) two times base salary plus bonus;
company-paid COBRA continuation coverage for 18 months post-termination; continuing life insurance benefits (if any) for two years;
and extended exercisability of outstanding vested options (for three years from termination date or, if earlier, the expiration
of the fixed option term). If termination of employment as described above occurs within six months before or two years after a
change in control of the Company, then, in addition to the above payments and benefits, all of Dr. Hayward&rsquo;s outstanding
options and other equity incentive awards will become fully vested and Dr. Hayward will receive a lump sum payment of the amounts
that would otherwise be paid as salary continuation. In general, a change in control will include a 30% or more change in ownership
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon termination due to death or disability,
Dr. Hayward will generally be entitled to receive the same payments and benefits he would have received if his employment had been
terminated by the Company without cause (as described in the preceding paragraph), other than salary continuation payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Effective June 21, 2014, Dr. Hayward&rsquo;s
annual salary was voluntarily reduced by $50,000 on an annual basis and the salary reduction continued throughout fiscal 2015.
This salary reduction is accrued and will be subject to repayment when and if, while Dr. Hayward remains continuously employed
by the Company, the Company reaches $3,000,000 in sales for two consecutive quarters or the Company has net income at the end of
any fiscal year. Effective January 1, 2015, the Chief Executive Officer&rsquo;s annual salary was voluntarily reduced by an additional
$50,000; however, this second reduction is not subject to repayment. Accordingly, his annual base salary is $250,000 as of the
fiscal year ended September 30, 2015 (with an additional $50,000 deferred subject to repayment under the circumstances described
above). For information on changes to Dr. Hayward&rsquo;s salary subsequent to September 30, 2015, see &ldquo;&mdash;Executive
Compensation Actions Taken in Fiscal 2016 (through April 19th, 2016).&rdquo;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Potential Payments upon Termination of Employment or a
Change of Control</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There is a change-in-control provision included
in Dr. Hayward&rsquo;s employment agreement, and we are obligated to pay severance or other enhanced benefits to him upon termination
of his employment. For additional information, see &ldquo;Employment Agreement&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dr. Hayward would have been entitled to
base salary continuation of $750,000 (three times his annual base salary) if his employment was terminated on September 30, 2015
by us without &ldquo;cause&rdquo; or by Dr. Hayward for &ldquo;good reason,&rdquo; extended exercisability of outstanding vested
options (for three years from termination date or, if earlier, the expiration of the fixed option term) and company-paid COBRA
continuation coverage for 18 months post-termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the context of a &ldquo;change in control&rdquo;
of the Company had it occurred on September 30, 2015, and within six months before or two years after such change in control Dr.
Hayward&rsquo;s employment was terminated by us without &ldquo;cause&rdquo; or by Dr. Hayward for &ldquo;good reason&rdquo;, he
would have been entitled to an estimated payment of $750,000 (three times his annual base salary) and other benefits set forth
in the preceding paragraph. In addition to the above payments and benefits, all of Dr. Hayward&rsquo;s outstanding options and
other equity incentive awards would have become fully vested and Dr. Hayward would have received a lump sum payment of the amounts
that would otherwise be paid as salary continuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If a &ldquo;change in control&rdquo; of
the Company occurred on September 30, 2015 and Dr. Hayward&rsquo;s employment was not terminated, then all of Dr. Hayward&rsquo;s
outstanding options and other equity incentive awards would have become fully vested.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Director Compensation: Fiscal 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the fiscal year ended September 30,
2015, we did not provide any cash compensation to our non-employee directors for their service on our Board of Directors. On November
30, 2011, the Board of Directors approved the recommendation from the compensation committee that each of the non-employee directors
shall annually receive, for as long as they are a member of the Board of Directors, a 10-year stock option, fully vested after
one year, to purchase a number of shares of common stock having a fair value of $60,000 as determined using the Black Scholes value,
or as determined by the compensation committee. Additionally, the Board of Directors approved the recommendation from the compensation
committee and Dr. James Hayward that stock options to purchase shares of our common stock having an aggregate fair value of $40,000
using the Black Scholes value be granted to certain non-employee directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Fees</b><br>
<b>Earned</b><br>
<b>or</b><br>
<b>Paid&nbsp;in</b><br>
<b>Cash</b><br>
<b>($)</b></td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Stock</b><br>
<b>Awards</b><br>
<b>($)</b></td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Option</b><br>
<b>Awards</b><br>
<b>($)&nbsp;(1)</b></td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>All&nbsp;Other</b><br>
<b>Compensation</b><br>
<b>($)</b></td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Total</b><br>
<b>($)&nbsp;(1)(3)</b></td>
    <TD NOWRAP>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td style="width: 31%"><i>Sanford R. Simon&nbsp;(2)</i></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 10%; text-align: right">&mdash;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 10%; text-align: right">&mdash;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 10%; text-align: right">91,590</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 14%; text-align: right">&mdash;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 10%; text-align: right">91,590</td>
    <td style="width: 1%">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><i>Yacov A. Shamash (2)</i></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">91,590</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">91,590</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td><i>John Bitzer, III (2)</i></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">91,590</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">91,590</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><i>Joseph D. Ceccoli</i></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">78,500</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">78,500</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <td><i>Charles S. Ryan (2)</i></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">91,590</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&mdash;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">91,590</td>
    <td>&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>A 10-year option to purchase 30,972 shares of our common stock was granted by the Board to each of the non-employee directors
on December 22, 2014 at an exercise price of $2.86 per share, with one year vesting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>A 10-year option to purchase an additional 5,162 shares of our common stock at an exercise price of $2.86 per share was granted
to Mr. Simon, Mr. Shamash, Mr. Bitzer and Mr. Ryan on December 22, 2014, with one year vesting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>The amounts represent the grant date fair value calculated in accordance with ASC 718 based on the Black Scholes value of the
options on the grant date. Information concerning these amounts and the assumptions used to calculate these amounts are set forth
in our Form 10-K for the fiscal year ended September 30, 2015 filed with the SEC on December 14, 2015 under the caption &ldquo;Item
7. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations &mdash;Equity Based Compensation.&rdquo;
As of September 30, 2015, Mr. Simon, Mr. Shamash, Mr. Bitzer, Mr. Ceccoli and Mr. Ryan had total outstanding option awards (including
warrants) of 84,467, 95,890, 72,016, 30,972 and 72,016 shares of our common stock, respectively.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Executive Compensation Actions Taken in Fiscal 2016 (through
April 19th)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following list sets forth actions taken
by the Company or the Board of Directors relating to the compensation of our named executive officers during fiscal year 2016 (to
April 19, 2016):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>On December 21, 2015, we granted Dr. James A. Hayward, Chairman and Chief Executive Officer, Dr. Ming-Hwa Liang, Chief Scientific
Officer and Secretary, Judith Murrah, Chief Information Officer, and Beth Jantzen, Chief Financial Officer, of the Company options
to purchase 50,000, 10,000, 50,000 and 50,000 shares of the Company&rsquo;s common stock, respectively, under our 2005 Incentive
Stock Plan at an exercise price of $2.99 per share for a term of 10 years. 25% of the options granted to each individual will vest
and become exercisable each anniversary of the grant date over four years, commencing on December 21, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Effective January 1, 2016, in view of the Company&rsquo;s performance during fiscal 2015, Dr. James A. Hayward&rsquo;s annual
salary was increased from $250,000 to $400,000 pursuant to approval by the compensation committee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Effective February 13, 2016, Ms. Beth Jantzen's annual salary was increased from $225,000 to $250,000.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_007"></A>CERTAIN RELATIONSHIPS
AND RELATED TRANSACTIONS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">James A. Hayward</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 11, 2014, we issued and sold
promissory notes (the &ldquo;Notes&rdquo;) in the aggregate principal amount of $1,800,000 and bearing interest at a rate of 12.5%
per annum to Dr. James A. Hayward, our President, Chairman and Chief Executive Officer (in the amount of $1,000,000) and another
individual (in the amount of $800,000) both of whom are &ldquo;accredited investors&rdquo; as defined in regulations promulgated
under the Securities Act. The Notes had a ten-month maturity. Interest was payable in cash or in shares of common stock at the
option of the holders of the Notes. The Notes could have been prepaid in whole or in part, at any time, subject to certain prepayment
penalties. Upon an event of default, the Notes and all accrued interest thereon would have automatically converted into common
stock at the closing price of the common stock on the date of issuance of the Notes. In the event of a consolidation or merger
with another corporation in which we did not survive, the Notes would have been paid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 11, 2014, Dr. Hayward and the
other individual agreed to exchange for cancellation their respective Notes (including principal and accrued interest thereon)
for 315,171 shares of common stock and warrants to purchase 315,171 shares of common stock, in the case of Dr. Hayward, and 252,137
shares of common stock and warrants to purchase 252,137 shares of common stock, in the case of the other individual, at $3.25,
the public offering price per share and warrant in our underwritten public offering which closed on November 20, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 20, 2014, Dr. Hayward purchased
$250,000 in common stock and warrants in our underwritten public offering on the same terms as the other investors in the offering.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Delabarta / John Bitzer, III</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">John Bitzer, III, one of our directors,
is President and Chief Executive Officer of ABARTA, a private, third- and fourth-generation family holding-company, which owns
Delabarta. On June 23, 2014, Delabarta, Inc. purchased 7,275 shares of our common stock at a purchase price of $6.87 per share
for gross proceeds of $50,000 in a private placement transaction. Delabarta, Inc. also received 7,275 warrants to purchase shares
of our common stock as part of this private placement transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 20, 2014, Delabarta purchased
$250,000 in common stock and warrants in our underwritten public offering on the same terms as the other investors in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_008"></A>SECURITY OWNERSHIP
OF CERTAIN BENEFICIAL OWNERS<BR>
AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth certain information
regarding the shares of our common stock beneficially owned as of April 11, 2016, (i) by each person who is known to us to beneficially
own 5% or more of the outstanding common stock, (ii) by each of the executive officers named in the table under &ldquo;Executive
Compensation&rdquo; and by each of our directors and (iii) by all executive officers and directors as a group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise indicated below, each person
or entity has an address in care of our principal executive offices at 50 Health Sciences Drive, Stony Brook, New York 11790.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <TD NOWRAP STYLE="vertical-align: bottom; border-bottom: Black 2px solid"><b>Name and Address of Beneficial Owner</b></td>
    <TD NOWRAP STYLE="vertical-align: bottom">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 2px solid"><b>Title of Class</b></td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 2px solid"><b>Number of</b><br>
<b>Shares Owned</b><br>
<b>(1)(2)</b></td>
    <TD NOWRAP STYLE="padding-bottom: 2px">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 2px solid"><b>Percentage</b><br>
<b>of Class</b><br>
<b>(3)</b></td>
    <TD NOWRAP>&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; width: 48%">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; width: 14%; text-indent: 3.1pt">&nbsp;</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 12%">&nbsp;</td>
    <TD NOWRAP STYLE="width: 8%">&nbsp;</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 1%">&nbsp;</td>
    <TD STYLE="width: 12%">&nbsp;</td>
    <TD STYLE="width: 1%">&nbsp;</td></tr>
<tr style="background-color: azure">
    <TD STYLE="vertical-align: bottom"><b>Executive Officers and Directors:</b></td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD>James A. Hayward</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">Common Stock</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">3,843,016</td>
    <TD NOWRAP>(4)</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">14.78</td>
    <TD>%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD>Yacov A. Shamash</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">Common Stock</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">95,890</td>
    <TD NOWRAP>(5)(17)</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>*</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD>John Bitzer, III </td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">Common Stock</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">1,304,842</td>
    <TD NOWRAP>(6)(7)(17)</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: right">5.39</td>
    <TD>%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD>Joseph D. Ceccoli</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">Common Stock</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">30,972</td>
    <TD NOWRAP>(16)(17)</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>*</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD>Beth M. Jantzen</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">Common Stock</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">55,834</td>
    <TD NOWRAP>(12)(14)</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>*</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD>Judith Murrah</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">Common Stock</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">97,289</td>
    <TD NOWRAP>(13)</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>*</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD>Charles S. Ryan</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">Common Stock</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">72,016</td>
    <TD NOWRAP>(6)(17)</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>*</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD>Ming-Hwa Benjamin &nbsp;Liang</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: center">Common Stock</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">220,803</td>
    <TD NOWRAP>(8)</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>*</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-bottom: 1.5pt">Sanford R. Simon</td>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">Common Stock</td>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD STYLE="border-bottom: Black 2px solid">&nbsp;</td>
    <TD STYLE="border-bottom: Black 2px solid; padding-bottom: 1.5pt; text-align: right">84,467</td>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt">(9)(17)</td>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</td>
    <TD STYLE="border-bottom: Black 2px solid">&nbsp;</td>
    <TD STYLE="padding-bottom: 1.5pt">*</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: azure">
    <TD STYLE="padding-bottom: 3pt"><b>All directors and officers as a group (9 persons)</b></td>
    <TD STYLE="padding-bottom: 3pt">&nbsp;</td>
    <TD STYLE="padding-bottom: 3pt; text-align: center">Common Stock</td>
    <TD STYLE="padding-bottom: 3pt">&nbsp;</td>
    <TD STYLE="border-bottom: Black 4px double">&nbsp;</td>
    <TD STYLE="border-bottom: Black 4px double; padding-bottom: 3pt; text-align: right">5,805,129</td>
    <TD NOWRAP STYLE="padding-bottom: 3pt">(10)</td>
    <TD STYLE="padding-bottom: 3pt">&nbsp;</td>
    <TD STYLE="padding-bottom: 3pt">&nbsp;</td>
    <TD STYLE="border-bottom: Black 4px double; text-align: right">21.67</td>
    <TD STYLE="padding-bottom: 3pt">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="background-color: azure">
    <TD STYLE="vertical-align: bottom"><b>5% Stockholder:</b></td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD NOWRAP>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-bottom: 3pt">Delabarta, Inc. (11)(15)</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 3pt">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 3pt; text-align: center">Common Stock</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 3pt">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; border-bottom: black 2.25pt double">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 4px double; padding-bottom: 3pt; text-align: right">1,205,959</td>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-bottom: 3pt">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 3pt">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 3pt">&nbsp;</td>
    <TD STYLE="border-bottom: Black 4px double; text-align: right">5.00</td>
    <TD STYLE="padding-bottom: 3pt">%</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">*</td>
    <td>indicates less than one percent</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(1)</td>
    <td>Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to the shares shown. Except as indicated by footnote and subject to community property laws where applicable, to our knowledge, the stockholders named in the table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them. A person is deemed to be the beneficial owner of securities that can be acquired by such person within 60 days upon the exercise of options, warrants or convertible securities (in any case, the &ldquo;Currently Exercisable Options&rdquo;).</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(2)</td>
    <td>Does not include the remaining unvested shares subject to options granted on October 14, 2013 pursuant to the 2005 Incentive Stock Plan, which vest 25% of the underlying shares ratably on each anniversary thereafter until fully vested on the fourth anniversary of the date of grant, including 2,084 to Ms. Jantzen. Does not include the remaining unvested shares subject to options granted on October 17, 2013 pursuant to the 2005 Incentive Stock Plan, which vest 25% of the underlying shares ratably on each anniversary thereafter until fully vested on the fourth anniversary of the date of grant, including 416,667 to James A. Hayward and 25,000 to Ming-Hwa Benjamin Liang. Does not include the remaining unvested shares subject to 16,667 options granted to Judith Murrah on December 2, 2013, pursuant to the 2005 Incentive Stock Plan, which vest 25% of the underlying shares ratably on each anniversary thereafter until fully vested on the fourth anniversary of the date of grant. &nbsp;Does not include the remaining unvested shares subject to options granted on December 21, 2015 pursuant to the 2005 Incentive Stock plan, which vest 25% of the underlying shares ratably on each anniversary date thereafter until fully vested on the fourth anniversary date of grant, including 50,000 for Dr. Hayward, Ms. Jantzen and Ms. Murrah and 10,000 for Dr. Liang.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(3)</td>
    <td>Based upon 24,075,092 shares of common stock outstanding as of April 11, 2016. Each beneficial owner&rsquo;s percentage
    ownership is determined by assuming that the Currently Exercisable Options that are beneficially held by such person (but not
    those held by any other person) have been exercised and converted.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(4)</td>
    <td>Includes 1,923,762 shares underlying currently exercisable options and warrants.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(5)</td>
    <td>Includes 95,890 shares underlying currently exercisable options and warrants.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(6)</td>
    <td>Includes 72,016 shares underlying currently exercisable options for Messrs. Bitzer and Ryan.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(7)</td>
    <td>Includes 1,129,036 shares of common stock and 76,923 currently exercisable warrants to purchase our common stock owned by Delabarta, Inc., a wholly-owned subsidiary of ABARTA, Inc. Mr. Bitzer is President and a member of the board of directors of each of Delabarta, Inc. and ABARTA, Inc. Mr. Bitzer disclaims beneficial ownership of the shares held by Delabarta, Inc. except to the extent of his pecuniary interest therein.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(8)</td>
    <td>Includes 211,667 shares underlying currently exercisable options and warrants.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(9)</td>
    <td>Includes 84,467 shares underlying currently exercisable options and warrants.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(10)</td>
    <td>Includes 2,719,381 shares underlying currently exercisable options and warrants.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(11)</td>
    <td>John Bitzer, III, one of our directors is President and Chief Executive Officer of the stockholder. Mr. Bitzer disclaims beneficial ownership of the shares held by the stockholder, except to the extent of his pecuniary interest therein.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(12)</td>
    <td>Includes 55,834 shares underlying currently exercisable options.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(13)</td>
    <td>Includes 95,834 shares underlying currently exercisable options.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(14)</td>
    <td>Does not include the remaining unvested shares subject to options granted on November 29, 2013, pursuant to the 2005
    Incentive Stock Plan, which vest 25% one year from the grant date, including 2,084 to Ms. Jantzen. Does not include the
    remaining unvested shares subject to options granted on February 15, 2015, pursuant to the 2005 Incentive Stock Plan, which
    vest 25% each anniversary over four years, commencing on February 15, 2016, one year from the date of grant, including 22,500
    to Ms. Jantzen.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(15)</td>
    <td>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This information is based on a Schedule 13G filed with the SEC
        on February 25, 2015 by Delabarta, Inc. and its parent company, ABARTA, Inc. Delabarta, Inc. reported sole voting and sole dispositive
        power of 1,213,234 shares of common stock, which includes 84,198 (76,923 remain outstanding) shares subject to warrants that are
        currently exercisable. John Bitzer, III, one of our directors is President and Chief Executive Officer of the stockholder. Mr.
        Bitzer disclaims beneficial ownership of the shares held by the stockholder, except to the extent of his pecuniary interest therein.
        As the parent company of Delabarta, Inc., ABARTA, Inc. may be deemed to be the indirect beneficial owner of the 1,213,234 shares
        beneficially owned by Delabarta, Inc. The address of the principal office of Delabarta, Inc. is 1105 North Market Street, Suite
        1300, Wilmington, Delaware, 19801. The principal office of ABARTA, Inc. is 200 Alpha Drive, Pittsburgh, Pennsylvania 15238.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>(16)</td>
    <td>Includes 30,972 shares underlying currently exercisable options.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0%">&nbsp;</td>
    <td style="width: 29px">(17)</td>
    <td>Does not include the remaining unvested shares subject
to options granted on December 21, 2015 pursuant to the 2005 Incentive Stock plan, which vest 100% of the underlying shares on
the anniversary date of the grant, including 28,636 for Messrs. Ceccoli and Simon, 32,455 for Messrs. Bitzer and Ryan and 40,091
for Mr. Shamash.</td></tr>
</table>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section 16(a) Beneficial Ownership Reporting Compliance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section&nbsp;16(a) of the Exchange Act
requires our officers and directors and persons who beneficially own more than 10% of any class of our equity securities
registered pursuant to Section 12 of the Exchange Act to file reports of securities ownership and changes in such ownership
with the SEC. Officers, directors and greater than 10% beneficial owners (&ldquo;10% stockholders&rdquo;) also are required
by SEC rules to furnish us with copies of all Section&nbsp;16(a) forms they file. Based solely upon a review of the copies of
such forms furnished to us during or with respect to the fiscal year ended September 30, 2015, as the case may be, and on
written representations from these reporting persons, we believe that none of our officers, directors or 10% stockholders
failed to file on a timely basis, as disclosed in the forms described above, reports required by Section 16(a) during fiscal
2015 or prior fiscal years, except for a Form 4 that was untimely filed to report one grant of options to purchase our common
stock to Beth Jantzen subsequent to the receipt of stockholder approval for such grant in fiscal 2015.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_009"></A>HOUSEHOLDING OF PROXY
MATERIALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC has adopted rules that permit companies
and intermediaries such as brokers to satisfy delivery requirements for proxy materials with respect to two or more stockholders
sharing the same address by delivering a single proxy statement addressed to those stockholders. This process, which is commonly
referred to as &ldquo;householding,&rdquo; potentially provides extra convenience for stockholders and cost savings for companies.
The Company, as well as some brokers (or other nominees), household the Company&rsquo;s proxy materials, which means that we or
they deliver a single proxy statement or Notice, as applicable, to multiple stockholders sharing an address unless contrary instructions
have been received from the affected stockholders. Once you have received notice from your broker (or other nominee) or from or
us that they or we will be householding materials to your address, householding will continue until you are notified otherwise
or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive
a separate proxy statement in the future, or if you are receiving multiple copies of the proxy statement and wish for only one
copy to be delivered to your household in the future, please notify (i) your broker (or other nominee) if your shares are held
in a brokerage or similar account or (ii) the Company if you hold registered shares in your own name. We will promptly deliver
a separate proxy statement to record stockholders upon written or oral request. You can notify us of your instructions by telephone
at 631-240-8800 or by sending a written request to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Corporate Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Applied DNA Sciences, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">50 Health Sciences Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Stony Brook, New York 11790</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_010"></A>OTHER BUSINESS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not know of any matters that are to
be presented for action at the Annual Meeting other than those set forth above.&nbsp;&nbsp;If any other matters properly come before
the Annual Meeting, the persons named in the enclosed proxy card will vote the shares represented by proxies in accordance with
their best judgment on such matters.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_011"></A>STOCKHOLDER PROPOSALS
AND NOMINATIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In order for a stockholder proposal to be
considered for inclusion in the proxy statement for the 2017 annual meeting of stockholders, the written proposal must be received
by the Corporate Secretary at the address below no later than <B>December 30, 2016</B>.&nbsp;&nbsp;In the event that the annual
meeting of stockholders is called for a date that is not within 30 days before or after the first anniversary of the date of this
year&rsquo;s annual meeting, the proposal must be received no later than a reasonable time before the Company begins to print and
mail its proxy materials.&nbsp;&nbsp;The proposal will also need to comply with the SEC&rsquo;s regulations under Rule 14a-8 under
the Exchange Act regarding the inclusion of stockholder proposals in company sponsored proxy materials.&nbsp;&nbsp;Proposals should
be addressed to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Corporate Secretary<BR>
Applied DNA Sciences, Inc.<BR>
50 Health Sciences Drive<BR>
Stony Brook, New York 11790</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For a stockholder proposal that is not
intended to be included in the proxy statement for the 2017 annual meeting of stockholders, or if you want to nominate a
person for election as a director, you must provide written notice to the Corporate Secretary at the address
above.&nbsp;&nbsp;The Secretary must receive this notice not earlier than <B>February 9, 2017</B> and not later than <B>March
10, 2017</B>.&nbsp;&nbsp;&nbsp;However, if our 2017 annual meeting of stockholders is held <I>more than 30 days before or
more than 60 days after June 8, 2017</I>, then the Secretary must receive this notice not earlier than the close of business
on the 120th day prior to the date of our 2017 annual meeting and not later than the close of business on the later of the
90th day prior to such annual meeting or the 10th day following the day on which we make a public announcement of the date of
the meeting.&nbsp;&nbsp;The notice of a proposed item of business must provide information as required in our bylaws which,
in general, require that the notice include for each matter a brief description of the matter to be brought before the
meeting; the reason for bringing the matter before the meeting; the text of the proposal or matter; your name, address, and
number of shares you own beneficially or of record; and any material interest you have in the proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The notice of a proposed director nomination
must provide information and documentation as required in our bylaws which, in general, require that the notice of a director nomination
include the information about the nominee that would be required to be disclosed in the solicitation of proxies for the election
of a director under federal securities laws; the nominee&rsquo;s written consent to be named in the proxy statement as a nominee
and to serve as a director if elected; a description of any transaction or arrangement during the last three years between the
stockholder making the nomination and the nominee in which the nominee had a direct or indirect material interest; and a completed
and signed questionnaire, representation and agreement.&nbsp;&nbsp;A copy of the bylaw requirements will be provided upon request
to the Corporate Secretary at the address above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="dna_012"></A>ANNUAL REPORT ON
FORM 10-K AND OTHER INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>A copy of our Annual Report on Form 10-K
for the fiscal year ended September 30, 2015, including financial statements and any financial statement schedules required to
be filed in accordance with SEC rules, will be sent without charge to any stockholder of the Company requesting it in writing from:&nbsp;&nbsp;Applied
DNA Sciences,&nbsp;Inc., 50 Health Sciences Drive, Stony Brook, New York 11790, Attention:&nbsp;&nbsp;Debbie Bailey. We also make
available, free of charge on our website, all of our filings that are publicly filed on the SEC&rsquo;s EDGAR website, including
Forms 10-K, 10-Q and 8-K, at <I>www.adnas.com</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt times new roman; width: 100%">
<tr style="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</td>
    <TD STYLE="width: 38%">By Order of the Board of Directors</td>
    <TD STYLE="width: 12%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ James A. Hayward</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>James A. Hayward</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <td colspan="2"><i>Chairman, President and Chief Executive Officer</i></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stony Brook, New York<BR>
April 29, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Appendix A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>
<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%">
        <P STYLE="font: 6pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><B><I>&nbsp;&nbsp;</I></B></P>
        <P STYLE="font: 6pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><IMG SRC="def14alogo.jpg" ALT="">&nbsp;</P>
        <P STYLE="font: 6pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">&nbsp;</P>
        <P STYLE="font: 6pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-size: 8pt"><B><I>APPLIED
        DNA SCIENCES, INC.</I></B></FONT></P>
        <P STYLE="font: 6pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-size: 8pt"><B><I>ATTN:
        DEBBIE BAILEY</I></B></FONT></P>
        <P STYLE="font: 6pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-size: 8pt"><B><I>50
        HEALTH SCIENCES DRIVE</I></B></FONT></P>
        <P STYLE="font: 6pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-size: 8pt"><B><I>STONY
        BROOK,NY 11790</I></B></FONT></P>
        <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</P></TD>
    <TD STYLE="width: 2%; font: 11pt Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="width: 50%"><P STYLE="font: 6.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt"><B>VOTE
        BY INTERNET - www.proxyvote.com</B></FONT></P>
        <P STYLE="font: 6.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt">Use
        the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern
        Time on June 7, 2016, the day before the meeting date. Have your proxy card in hand when you access the web site and follow
        the instructions to obtain your records and to create an electronic voting instruction form.</FONT></P>
        <P STYLE="font: 7.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
        <P STYLE="font: 6.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt"><B>ELECTRONIC
        DELIVERY OF FUTURE PROXY MATERIALS</B></FONT></P>
        <P STYLE="font: 6.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt">If
        you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all
        future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic
        delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree
        to receive or access proxy materials electronically in future years.</FONT></P>
        <P STYLE="font: 7.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
        <P STYLE="font: 6.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt"><B>VOTE
        BY PHONE - 1-800-690-6903</B></FONT></P>
        <P STYLE="font: 6.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt">Use
        any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time on June 7, 2016 the day before
        meeting date. Have your proxy card in hand when you call and then follow the instructions.</FONT></P>
        <P STYLE="font: 7.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
        <P STYLE="font: 6.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt"><B>VOTE
        BY MAIL</B></FONT></P>
        <P STYLE="font: 6.5pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-size: 8pt">Mark,
        sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing,
        c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 7pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 7pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 7pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 7pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 7pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" NOWRAP STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; border-bottom: Black 1.5pt dashed"><FONT STYLE="font-size: 7pt">TO VOTE, MARK BLOCKS BELOW IN &nbsp;BLUE OR BLACK INK AS FOLLOWS:</FONT></TD>
    <TD NOWRAP STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; border-bottom: Black 1.5pt dashed"><FONT STYLE="font-size: 7pt">KEEP THIS &nbsp;PORTION FOR YOUR RECORDS DETACH</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="font: 7pt Calibri, Helvetica, Sans-Serif; width: 28%">&nbsp;</TD>
    <TD NOWRAP STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center; width: 44%"><FONT STYLE="font-size: 8pt">THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.</FONT></TD>
    <TD NOWRAP STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right; width: 28%"><FONT STYLE="font-size: 7pt">AND RETURN &nbsp;THIS &nbsp;PORTION ONLY</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; font-size: 3pt">
    <TD STYLE="width: 1%; border-right: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 2%; border-top: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 2%; border-top: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 16%; border-top: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 8%; border-top: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 5%; border-top: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 3%; border-top: gray 2.25pt solid; text-align: center; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 6%; border-top: gray 2.25pt solid; text-align: center; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 5%; border-top: gray 2.25pt solid; text-align: center; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 31%; border-top: gray 2.25pt solid; text-align: justify; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-top: gray 2.25pt solid; text-align: justify; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 2%; border-top: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-top: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 2%; border-top: gray 1.5pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 2%; border-top: gray 1.5pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 4%; border-top: gray 1.5pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-top: gray 1.5pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 6%; border-top: gray 1.5pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 2%; border-top: gray 1.5pt solid; border-right: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="width: 0%; font-size: 3pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt"><B>For</B></FONT><BR>
<FONT STYLE="font-size: 7pt"><B>All</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;Withhold&nbsp;</B></FONT><BR>
<FONT STYLE="font-size: 7pt"><B>All</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="padding-right: 12.2pt; text-align: center"><FONT STYLE="font-size: 7pt"><B>For All</B></FONT><BR>
<FONT STYLE="font-size: 7pt"><B>Except</B></FONT></TD>
    <TD ROWSPAN="4" STYLE="text-align: justify"><FONT STYLE="font-size: 7pt">T<FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 6pt">o withhold authority to vote
for any individual nominee(s), mark &ldquo;For All Except&rdquo; and write the number(s) of the nominee(s) on the line below.</FONT></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt"><B>The Board of Directors recommends you vote FOR the following:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD ROWSPAN="16" STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 7pt">o</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 7pt">o</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 7pt">o</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7pt"><B>1.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">Election of Directors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"></TD>
    <TD STYLE="text-align: center"></TD>
    <TD STYLE="text-align: center"></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 0.125in"><FONT STYLE="font-size: 7pt"><B>Nominees</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7pt">01</FONT></TD>
    <TD COLSPAN="15"><FONT STYLE="font-size: 7pt">James A. Hayward &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;02 John Bitzer, III &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;03 Joseph D. Ceccoli &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;04 Charles Ryan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;05 Yacov Shamash</FONT></TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7pt">06</FONT></TD>
    <TD COLSPAN="15"><FONT STYLE="font-size: 7pt">Sanford R. Simon</FONT></TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR>
    <TD ROWSPAN="23" STYLE="vertical-align: bottom; border-right: gray 2.25pt solid"><IMG SRC="def14av1.jpg" ALT=""></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="9"><FONT STYLE="font-size: 7pt"><B>The Board of Directors recommends you vote FOR proposals 2. and 3.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 7pt"><B>For</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt"><B>Against</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt"><B>Abstain</B></FONT></TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="7">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7pt"><B>2.</B></FONT></TD>
    <TD COLSPAN="7"><FONT STYLE="font-size: 7pt">Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center"></TD>
    <TD COLSPAN="2" STYLE="text-align: center"></TD>
    <TD STYLE="text-align: center"></TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 7pt">o</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 7pt">o</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 7pt">o</FONT></TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7pt"><B>3.</B></FONT></TD>
    <TD COLSPAN="7"><FONT STYLE="font-size: 7pt">Ratification of the selection of Marcum LLP as our independent registered public accounting firm for the
fiscal year ending September 30, 2016.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Wingdings; font-size: 7pt">o</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Wingdings; font-size: 7pt">o</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Wingdings; font-size: 7pt">o</FONT></TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="16"><FONT STYLE="font-size: 7pt"><B>NOTE: </B>Such other business as may properly come before the meeting or any adjournment thereof.</FONT></TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="12"><FONT STYLE="font-size: 7pt">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator,
or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation
or partnership, please sign in full corporate or partnership name, by authorized officer.</FONT></TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="10">&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-size: 6pt">
    <TD STYLE="border-right: gray 2.25pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" ROWSPAN="3" STYLE="border-top: black 1.5pt solid; border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="3" STYLE="border-top: black 1.5pt solid; border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" ROWSPAN="3" STYLE="border-top: black 1.5pt solid; border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" ROWSPAN="3" STYLE="border-top: black 1.5pt solid; border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: right; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: gray 2.25pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-size: 6pt">
    <TD STYLE="border-right: gray 2.25pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: right; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: gray 2.25pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-size: 6pt">
    <TD STYLE="border-right: gray 2.25pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1.5pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: right; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: gray 2.25pt solid; font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 6pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-top: black 1.5pt solid"><FONT STYLE="font-size: 7pt">Signatur<FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">e [PLEASE SIGN WITHIN
BOX]</FONT></FONT></TD>
    <TD STYLE="border-top: black 1.5pt solid"><FONT STYLE="font-size: 7pt">Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"></TD>
    <TD STYLE="border-top: black 1.5pt solid"><FONT STYLE="font-size: 7pt">Signatur<FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 7pt">e (Joint Owners)</FONT></FONT></TD>
    <TD STYLE="border-top: black 1.5pt solid">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-top: black 1.5pt solid"><FONT STYLE="font-size: 7pt">Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: gray 2.25pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font-size: 3pt">
    <TD STYLE="border-right: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="border-bottom: gray 1.5pt solid; border-right: gray 2.25pt solid; font-size: 3pt">&nbsp;</TD>
    <TD STYLE="font-size: 3pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font: 8pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt"><B>Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 9pt">The
    Notice &amp; Proxy Statement and Annual Report on Form 10-K are available at <FONT STYLE="color: blue">&nbsp;<U>www.proxyvote.com</U></FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; border-bottom: Black 1.5pt dashed">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: center; border-left: Black 2.25pt solid; border-top: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="width: 91%; text-align: center; border-top: Black 2.25pt solid"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt"><B>APPLIED DNA SCIENCES, INC.</B></FONT></TD>
    <TD STYLE="width: 4%; text-align: center; border-right: Black 2.25pt solid; border-top: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="padding-top: 0.5pt; text-align: center"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt"><B>Annual Meeting of Stockholders</B></FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="padding-top: 0.5pt; text-align: center"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt"><B>June 8, 2016 10:00 AM</B></FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="padding-top: 0.5pt; text-align: center"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt"><B>This proxy is solicited by the Board of Directors</B></FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="padding-top: 0.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt">The stockholder
    executing and delivering this Proxy hereby appoints Ms. Debbie Bailey and Ms. Beth Jantzen and each of them as proxies (the
    &ldquo;proxies&rdquo;), with full power of substitution, and hereby authorizes them to represent and vote, as designated
    below, all shares of common stock, $0.001 par value per share, of Applied DNA     Sciences,     Inc. held     of     record
    by the undersigned as of April 11, 2016, at the Annual Meeting of Stockholders of Applied DNA Sciences, Inc., to     be
    held     at     the Center of Excellence in Wireless and Information Technology, 1500 Stony Brook Rd. Stony Brook, New York
    11794,       at     10:00 a.m., local time, on Wednesday, June 8, 2016, or at any postponements or adjournments of the
    meeting.</FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt">This Proxy, when properly executed, will be voted in the manner directed herein by the undersigned stockholder. If no direction is made, this Proxy will be in accordance with the recommendations of our Board of Directors and for such other matters as may properly come before the meeting as said proxies deem advisable.</FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt">THIS PROXY SHOULD BE MARKED, DATED AND SIGNED BY THE STOCKHOLDER(S) EXACTLY AS SUCH STOCKHOLDER&rsquo;S NAME APPEARS HEREON AND RETURNED PROMPTLY IN THE ENCLOSED ENVELOPE. PERSONS SIGNING IN A FIDUCIARY CAPACITY SHOULD SO INDICATE. IF SHARES ARE HELD BY JOINT TENANTS OR AS COMMUNITY PROPERTY, BOTH SHOULD SIGN.</FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: middle"><IMG SRC="def14av2.jpg" ALT=""></TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-left: Black 2.25pt solid; border-bottom: Black 2.25pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 2.25pt solid"><FONT STYLE="font-family: Calibri, Helvetica, Sans-Serif; font-size: 10pt"><B>Continued and to be signed on reverse side</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 2.25pt solid; border-right: Black 2.25pt solid">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>def14alogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 def14alogo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )@#N P$1  (1 0,1 ?_$ '(   (" 04! 0
M       )!P@* 0($!08#"P$!                     !    8" @$#! $$
M @(#     @,$!08' 0@1"0 2$Q0A,14*%D%1(B,R%V&!<<$9$0$
M            _]H # ,!  (1 Q$ /P#/X\ \ \ \ \ \ \ \ \ \ \ \ \ \
M \ \ \ \ \ \ \ \ S],9_K_ ./[^ F7?#OTZQ^O@YXC5M7XWSVW&@HS(Z1H
MY,79MA@6 P9PWO9K8J(AD+6^X#&,E/CLVG8P+ @@%CP,<=U_9W[3MYY6.)]4
M?6N,<=(=4)0K#LMND%FX"E+6%@&&32!"MKJGZX X&!RG,RO>%@2@9'D!X1\"
M+#.BKY?)G6#P]SFS>SM$V<(M'E<R:(\XY=V%HEA[4E,DC4RNF1"RX-3<]"/)
M(/SG.32@8%G[^![#P#P#P#P-@QA+"(8\X" (<B$(6<!"$(<9$(0A"S@(0AQC
MZYSGC'@=<SOC-(407)A=FQ[;AF'$@7M"](YHA')S,E'DA5(CCR!&DFAR$8<"
MY"+&<9XSX&U4_,B%R;V9:\-:1X=L'":FI2X(T[DYA3!]:D3>@./ J6A3@^H_
M; +TX^N? YRA6F2$'JE1Y29,F*,/4J%!I9!"<DH.1FFGG&B 6246 .1"$+.
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MY7?9OL/6K-;>S?7C<M_F=M1N<2Q_&U1>#VE04<F;QA9#HP-Q+(=&\UK2H6_
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M5GIO^Q''[87X4NL9>)?H%4YT$2R41WRR3'2.5^]0Q>B;3%&.,_C3TXDV<^X
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E2HDK/@>?\2P8](< _P"#Z.1>G_ES_E]^?M_7GZ^!O\ \ \#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>def14av1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 def14av1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1@ ) P$1  (1 0,1 ?_$ &8  0$! 0
M      D'" H! 0                     0  $%  (! 00+ 0        4"
M P0&!P$( !,4%946\!'1$B)24]16%QC6$0$                     _]H
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@SFT _/[ O\IMB!:!W-I1(XDBE2%S$Q)7I(2"(^!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>def14av2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 def14av2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 20 ) P$1  (1 0,1 ?_$ &<  0$! 0
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M*S!:? )^J!KHLAZGC1J?[IS:0K3T0]F"J-#R6@FRAR_V*FB#8-M"F 0&'3$
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#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )@$6 P$1  (1 0,1 ?_$ +D    %!0$!
M       " P@) 00%!@<*"P$!  $% 0$               0! @,%!@<($
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MM==FTMX:BL5DK:>DFM,TU=JG8SNM)2';(I 6+J2$<B9FY:?)*97MFY"(FV,
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$_O+_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>pg21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pg21.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ #@ + P$1  (1 0,1 ?_$ &4  0$
M      <( 0$                     $    @<' 0D!           %!@$1
M @,3! < $A05%A<((R$Q02(S1#88&0D1 0                    #_V@ ,
M P$  A$#$0 _ *T_N)RV,?)RKA/HKPP,E4S@8J)S\T[J<&TX Y]L(#IY],(3
MB'PG+O&&7\[(W$]-*5)58$C] GVC,;K*N4;\[-B(FC&L3]D=^L@B0[_RC ]*
M'WX3SV"2Y-\(4\/?.T$IF'B'(2B1BK*D3/QRI *F.F]7J?GM,V\:8+<F&F )
M"SH.@B&5LOY@-DIL/\4O56 ,C@6A[^5'CT-00,^-\9?V'P^W\73J]V?<YJJY
( Z:E=M@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>pg21a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pg21a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ #@ + P$1  (1 0,1 ?_$ &X  0$!
M      @'"0$! 0$                   $"$    @8'!P4!           $
M!0$" Q,&!P 1$A06%P@A,C05& D902)"(R0*$0$  @,
M 1%1H='_V@ , P$  A$#$0 _ %9_17K9E_,N+H?TTRZC>*P4727B<:O,0$!#
MKAX>;&*R%&:H-<8R:,Q"Y@6K*I2A"/;70!CY+)?8-Y9F/.F_^-WIDO-P#/,T
M<^<78AK>\-AK\KW?=[*!..[Q+.5:W<#U&FQ+J.@9!B;S",A\50N;P7-\,80F
M?M%TI'$;8>7RV-",V4#IV/PHIJR6]%DTM,W.)UUGQEG %QM=1<KGN&KT[PC.
7[C,1NN5V\KK-=R^U[N?&NU07.)UU_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
